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1. Abstract 
 
Retrotransposons, which used to be considered as “junk DNA”, have begun to reveal 
their immense value to genome evolution and human biology due to recent studies. They 
consist of at least ~45% of the human genome and are more or less the same in other 
mammalian genomes. Retrotransposon elements (REs) are known to affect the human 
genome through many different mechanisms, such as generating insertion mutations, 
genomic instability, and alteration in gene expression. Previous studies have suggested 
several RE subfamilies, such as Alu, L1, SVA and LTR, are currently active in the human 
genome, and they are an important source of genetic diversity between human and other 
primates, as well as among humans. Although several groups had used Retrotransposon 
Insertion Polymorphisms (RIPs) as markers in studying primate evolutionary history, no 
study specifically focused on identifying Human-Specific Retrotransposon Element (HS-
RE) and their roles in human genome evolution. In this study, by computationally 
comparing the human genome to 4 primate genomes, we identified a total of 18,860 HS-
REs, among which are 11,664 Alus, 4,887 L1s, 1,526 SVAs and 783 LTRs (222 full 
length entries), representing the largest and most comprehensive list of HS-REs generated 
to date. Together, these HS-REs contributed a total of 14.2Mb sequence increase from the 
inserted REs and Target Site Duplications (TSDs), 71.6Kb increase from transductions, 
and 268.2 Kb sequence deletion of from insertion-mediated deletion, leading to a net 
increase of ~14 Mb sequences to the human genome. Furthermore, we observed for the 
first time that Y chromosome might be a hot target for new retrotransposon insertions in 
general and particularly for LTRs. The data also allowed for the first time the survey of 
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frequency of TE insertions inside other TEs in comparison with TE insertion into none-
TE regions. In summary, our data suggest that retrotransposon elements have played a 
significant role in the evolution of Homo sapiens. 
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6.Introduction 
 
Transposable elements (TEs) are defined as DNA sequences which can change their 
positions in the genome. Although they were first discovered by McClintock back in the 
1940s [1], they had been overlooked and thought to be “junk genes” for about 50 years. It 
was only after the availability of genome sequences for many species that researchers 
began to have a better appreciation of their abundance and function in the genomes [2].  
TEs can be divided into two major classes: DNA transposons and retrotransposon 
elements (REs). In the human genome, the vast majority of TEs are retrotransposons, 
making up at least 51% of the genome, while DNA transposons make up 3.5% of the 
genome (Figure 1). DNA transposons are able to excise themselves from the genome and 
travel to new genome sites in the form of DNA, but in human genome they have lost this 
ability ~37 million years ago [3, 4]. Retrotransposons mobilize to new locations in the 
genome via an RNA-based duplication process called retrotransposition [4]. Depending 
on the presence or absence of long-terminal repeats (LTRs), retrotransposons can be 
divided into LTR retrotransposons and non-LTR retrotransposons. The largest class of 
LTR-retrotransposons is endogenous retroviruses (ERVs), and they account for ~9.3% of 
the human genome. Most of these LTRs have lost their mobilization ability and are 
possessed by all members in the human population. Evidence suggests that very few of 
them still have ongoing retrotransposition activity [5, 6].  The non-LTR retrotransposons 
can be further divided into two classes: autonomous retrotransposons and non-
autonomous retrotransposons, depending on whether they encode genes necessary for 
their transposition. The LINE-1(L1), Alu and SVA elements, have the highest 
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retrotransposition ability and are responsible for ~55% of human TEs (Figure 1) [2]. 
Also, they are shown to be currently active in the human genome.  de novo insertion are 
known to be responsible for genetic disorder in more than 80 cases [7-10]. This study will 
focus on identifying human-specific retrotransposon insertions and evaluating their 
impact on genome evolution because they are by far the largest and most active TE 
groups. More detailed descriptions about REs that are known to remain active are 
provided in the next sections,   
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 Figure 1. The transposable element content of the human genome. 
Panel A is adapted by permission from Macmillan Publisher LTD: Nature Review Genetics, copyright 
(2009) Figure 1 in “The impact of retrotransposons on human genome evolution” by Cordaux R and Batzer 
MA [11]. About 45% of the human genome can currently be recognized as being derived from transposable 
elements, the vast majority of which are non-LTR retrotransposons such as L1, Alu and SVA elements. 
Panel B is developed using data from the RepeatMasker data provided by the UCSC genome website 
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(http://genome.ucsc.edu), which is more updated and indicates that transposable elements constitute ~51.5% 
of the human reference genome (hg19).  
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6.1. Human retrotransposons 
6.1.1. LINE-1 elements 
Having their own enzymatic machinery for retrotransposition, L1s are the only 
known autonomous non-LTR retrotransposons that are currently active within the human 
genome. Their continued mobilization activity in the last 150 million years has led to 
~500,000 copies in the human genome [2]. Consisting of ~18% of the human genome, 
L1s are the most successful TEs in the human genome by sequence length. A full-length 
L1 is about 6,000 base pairs long and is made of an internal RNA polymerase II 
promoter, two open reading frames (ORF1 and ORF2) and a polyadenylation signal 
followed by a homopolymeric tract of adenosines (polyA-tail)[12, 13]. The ORF1 gene 
encodes a RNA-binding protein and ORF2 encodes a protein with endonuclease and 
reverse transcriptase activity [14-16]. The process, which provides L1s the ability to 
mobilize in the human genome, is known as target-primed reverse transcription (TPRT) 
(Figure 2). Not all members of the L1 family retain this ability; most of them have lost 
this ability because of truncations, internal rearrangements and mutations [17]. Research 
suggests that there are no more than 100 copies of L1s that are still active. This is a small 
number comparing to the total ~ 500,000 copies in the human genome [18]. Also, it was 
suggested that only a few “hot” L1s are responsible for the bulk of new insertions [18]. 
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 Figure 2. A schematic diagram of target-primed reverse transcription (TPRT). 
This figure was adapted by permission from Macmillan Publisher LTD: Nature Review Genetics, copyright 
(2009), Box 1 in “The impact of retrotransposons on human genome evolution” by Cordaux R and Batzer 
MA [11]. A: Cleavage of first DNA strand at the target site by the retrotransposon endonuclease (EN); B: 
The retrotransposon RNA anneals at the nick site and starts reverse transcription by the retrotransposon 
reverse transcriptase (RT); C: Cleavage of second DNA strand. D: Integration at the double-strand break 
and removal of RNA and completion of DNA synthesis, leading to the insertion of a new copy of the 
retrotransposon at the target site and generation of target site duplications (TSDs).  
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6.1.2. Alu elements 
Alu elements have been active in the past ~65 million years (My), which resulted in 
more than 1 million Alu copies present in the current human genomes [2, 19]. This makes 
Alu to be the most abundant REs in number. Considering that Alu elements are primate-
specific and therefore relatively young, its rate of propagation is even more remarkable. A 
canonical full-length Alu element has ~300 base pairs and a dimeric structure made of 
two non-identical monomers, which were derived from the 7SL RNA gene (also known as 
the signal recognition particle RNA, a component of the signal recognition particle), 
connected by an adenosine-rich linker[20-22]. Alu transcripts may extend into the 
downstream flanking sequence until a terminator is found, leading to the formation of 3’ 
transduction, because Alu lacks RNA polymerase III termination signals [23, 24]. Being 
non-autonomous retrotransposons, Alu elements have to borrow the reverse transcriptase 
machinery of L1 elements since they lack of any coding capacity [25]. 
 
6.1.3. SVA elements 
SVA elements, which originated ~25My ago, now have ~3000 copies in the human 
genome[26]. SVA is a retrotransposon family found only in hominoids (the group of 
primates comprising human and apes, which diverged from Old World monkey about 25 
My ago) [26]. Shen et al. first used the term “SVA” (SINE-R, VNTR, and Alu) to 
describe this class of composite retrotransposons [27]. A full-length SVA element is ~2kb 
long and has a hexamer repeat region, an Alu-like region, a variable number of tandem 
repeats (VNTR) region, and a human endogenous retroviruses (HERV)-K10-like region 
followed by a polyadenylation signal ending with a polyA-tail [26, 28]. They might rely 
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on promoter activity in flanking regions since they lack an internal promoter [26, 28]. 
Like Alu elements, SVA elements are non-autonomous TEs, and they have to borrow the 
reverse transcriptase machinery from L1s as well [26, 28]. 
 
6.1.4. ERV elements  
Endogenous retroviruses (ERVs), which closely resemble infectious retroviruses in 
the human genome, are LTR retrotransposons [29]. They are results of ancestral infection 
by exogenous retroviruses. The human ERV (HERV) now contributes ~9% of the human 
genome, and most HERV subfamilies have lost the ability to retrotranspose. A typical 
full-length HERV consists of the main retroviral genes gag, pol, and env, flanked by long 
terminal repeats (LTRs). The ERV retrotransposons have the largest size among all four 
types of retrotransposons (average 7~12kb). Additionally, the ERV retrotransposons can 
form solo-LTR through homologous recombination between the two LTR sequences that 
are almost identical. The majority of HERV can be found in other primate genomes, 
indicating that they might have originated in our ancestors at least 25 My ago[30]. 
Currently, HERV-K is the only subfamily that has known activity in the human genome 
[31].  
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6.2. Impact on genome evolution 
Because of their continuous retrotransposition activity over the past tens of My, non-
LTR retrotransposons have had a great impact on both genome structure and function 
which in turn has had a tremendous impact on primate genome evolution. How frequently 
does retrotransposition happen in germline? This is vital for us to understand how much 
impact TEs have on genome evolution. Research suggests that the current rate of 
retrotransposition is around one insertion varies from every ~20 to ~900 births within 
different types of TEs [32-34]. For example, researchers have estimated the current rate 
of Alu retrotransposition to be one insertion every ~20 births in humans [32, 35]. Yet 
because of the potential bias brought by the small datasets available, it is very difficult to 
give an accurate estimation on the amplification rates. In addition to germline, several 
groups have demonstrated that retrotransposition can occur in somatic tissues as well, 
with associations ranging from cancer to a possible role in brain development [34, 36]. 
Provided in the following subsections are descriptions of the major mechanisms for RE’s 
impact on human genome evolution and function. 
 
6.2.1.  Impact on human genome structure 
There are many ways that retrotransposons can affect genome structure; they can 
either create local genomic instability or cause genome rearrangements such as deletions, 
duplications and inversions. By inserting themselves into protein-coding or regulatory 
regions, retrotransposons can affect gene function and expression (Figure 3). These 
retrotransposons were the first to be detected because they may have a visible impact via 
phenotype [7]. Up to date, there are more than 100 cases of human genetic disorders 
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reported to be associated with de novo L1, Alu and SVA insertions, including 
haemophilia, cystic fibrosis, Apert syndrome, neurofibromatosis, Duchenne muscular 
dystrophy, β-thalassemia, hypercholesterolemia and breast and colon cancers [8, 10, 37]. 
Recent studies suggest that the ORF2 protein of L1s can cause many more DNA 
double-strand breaks (DSBs) than those caused by the actual L1 insertions (Figure 3) 
[38]. L1 elements have also been found to be associated with DSBs repair through an 
endonuclease-independent manner (ENi). ENi L1 insertions show a different pattern than 
TPRT, therefore suggesting that L1s can integrate into DSBs DNA lesions and repair 
them [39]. The ENi retrotransposition might be an ancient mechanism of RNA-mediated 
DNA repair before the acquisition of an endonuclease domain [40, 41]. Additionally, 0.5-
0.7% of all L1 and Alu insertions has non-canonical structure and possibly derived from 
ENi retrotransposition [42, 43]. This suggests that ENi might be a general mechanism in 
non-LTR retrotransposons rather than just L1s. However, the repair of L1-mediated DSB 
damage does not necessarily need the involvement of L1s. This might suggest that a good 
proportion of the genomic instability associated with DSBs is contributed by L1 activity. 
However, it is not clear to what extent this mechanism contributes to human genome 
instability since most of these data were obtained from in-vitro experiments. Studies on 
Alu elements suggested that non-LTR retrotransposons can create microsatellites at many 
loci in the human genome because of their large copy numbers and their homopolymeric 
tracts (Figure 3) [44, 45]. Alu elements have two potential sources of microsatellites: the 
linker region in the middle and the 3’ oligo dA-rich tail. These homopolymeric repeats 
can experience various mutational like Single Nucleotide Polymorphisms (SNPs), which 
may create microsatellites of varying length and complexity. 
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Alu elements have been shown to be able to undergo recombination between their 
homologous chromosomal alleles, which has been proposed as a mechanism for gene 
conversion. Gene conversion might also play a role in the evolution of Alu elements, as it 
might be able to inactivate active Alu elements or reactivate inactive copies [46, 47]. 
While inserting themselves into the genome, retrotransposons normally create a type 
of structural rearrangement called target site duplication (TSD), in addition to the inserted 
RE sequences. This will be discussed in the next section 6.2.1.1. Instead of TSD, 
insertion of retrotransposons can sometimes cause the deletion of target genomic 
sequences simultaneously (Figure 3). Possible mechanisms include endonuclease-
dependent and ENi mechanisms. L1 and Alu insertion mediated-deletions are shown to be 
usually shorter and happen with a much lower frequency in the human and chimpanzee 
genomes than in cultured cells. This might suggest the involvement of a possible negative 
selection against large retrotransposon insertion-mediated deletions [48, 49]. 
L1 and Alu elements can perform non-allelic homologous recombination (NAHR) to 
generate structural variation at the post-insertion stage because of their extremely high 
copy numbers in the human genome and high level of sequence similarity among 
members from the same family (Figure 3). It can lead to many types of genomic 
rearrangements such as deletions, duplications and inversions. For example, Alu 
recombination-mediated deletions (RMD) can occur in the human genome. More than 70 
Alu RMDs have been reported to be associated with various forms of cancer and genetic 
disorders [8, 9]. 
L1s and SVA elements can sometimes generate 5’ or 3’ transduction, which means 
they can carry upstream or downstream flanking sequences with them to new loci in the 
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human genome (Figure 3). This may be caused by different levels of polyadenylation or 
promoter signal strength [50, 51]. This is the mechanism causing exon shuffling which 
will be later discussed in section 6.2.1.2. 
 
 
Figure 3 Impact of retrotransposon elements on human genome structure. 
This figure was adapted by permission from Macmillan Publisher LTD: Nature Review 
Genetics, copyright (2009), from Figure 2 in “The impact of retrotransposons on human 
genome evolution” by Cordaux R and Batzer MA [11].  
Panel A: Different RE mechanisms which can generate local genome instability. a: REs 
(red box) can create insertion mutagenesis depending on genic location of the integration 
site(light blue boxes); b: L1s have known ability to create DNA double strand breaks by 
its protein product ORF1 (green circle) as well as repair existing DSBs by non-canonical 
endonuclease-independent insertion(red box); b: Homopolymeric tracts carried by REs 
(red box) can generate microsatellites.  
Panel B: Several RE mechanisms which contribute to genome rearrangements. a: REs 
(red box) have known ability of co-retrotransposition of downstream or/and upstream 
flanking sequences (blue boxes). b: An RE insertion (red box) can sometime result in 
deletion of the pre-integration site sequences (blue boxes). c: Homologous recombination 
is possible between non-allelic homologous REs (red boxes). This could result in either 
deletion or duplication of genomic sequences between those REs (blue boxes).  
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6.2.1.1. Target site duplication 
 
Unlike other variations such as single nucleotide polymorphisms (SNPs) and copy 
number variations (CNVs), TE insertions have some unique characteristics. Target site 
duplication (TSD) is the hallmark of TE insertion.  
In the late 1970s, several research groups noticed that the TEs tended to have a pair 
of short repeats alongside the insertion sequence [1, 52, 53]. The TSDs are generated by 
the transposition process. Because of the staggered cleavage of the double strand DNA 
(Figure 2), most TE transposition would leave a pair of short repeats of sequence at the 
integration site on each side of the insertion. This is the direct evidence of a TE insertion 
event. As different types of TEs utilize different mechanisms for transposition inside 
human genome, they have different patterns for TSDs, which vary in length from several 
bps to several dozen bps and also likely in sequence signature. Therefore, TSDs can be 
used as an important tool to identify retrotransposon insertion events and to study the 
mechanism differences between different RE families. 
Generation of TSD serves as TE’s mechanism second to insertion of REs causing the 
genome to increase in size. Although each TSD only provides several bps to several 
dozen bps, their abundant copy number would be responsible for increasing megabases of 
primate genome.  Also, as previously discussed, 0.5-0.7% of all L1 and Alu insertions are 
proved to have non-canonical structure in which case the TSDs are absent [42, 43]. 
Therefore, the lack of TSDs could be used as evidence to identify non-canonical RE 
insertion events. 
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 6.2.1.2. Transduction 
 
The 3’ transduction by L1 elements in human genome was first reported in 
1994[54]. They discovered that a 3’ transduction alongside the insertion of a L1 insertion 
into the dystrophin gene caused muscular dystrophy in a single human individual.  
In the case of 3’ transduction, a read-through transcript of the RE element 
transcribes flanking genomic region downstream by virtue of a weak L1 termination and 
polyadenylation signal. Transduction of adjacent genomic DNA by RE elements may 
result in the creation of new exons and alteration of gene expression through promoter 
and enhancer shuffling [55]. It was estimated that ~20% of all L1 elements are associated 
with 3’ transduction.  
5’ transduction occurs commonly in some SVA subfamilies [51] at an estimated rate 
of ~8%. In the case of 5’ transduction, retrotransposon transcription is likely driven by an 
external promoter located in the 5’ region of a RE, bringing in extra sequences upstream of 
the parent RE to the new site. Similar to the 3’ transduction events, the 5’ transduction events 
have known disease association. As an example, a group reported a disease associated L1 
mediated 5’ transduction event in mice [56].   
 
6.2.1.3. Insertion mediated deletion 
 
In the case of retrotransposon insertion-mediated deletion, the RE sequences have a 
non-canonical structure: lack of TSDs, non-canonical endonuclease nick sites and 
sometimes the absence of an oligo-dA rich tail. Researchers first reported L1-mediated 
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deletion in 2002. In vivo and in vitro studies suggested that L1 retrotransposition events 
could result in significant deletion of genomic sequences spanning from 1 bp to 70,000 
bp at a rate of 10% [57-59]. If 10% of all L1 retrotransposons in the human genome 
induced deletion, millions of bases could have been deleted. If the deleted target site 
DNA is located in genic regions, it might have potential association with disease. For 
example, a 1-bp deletion in the DMD gene by a L1 element has been reported to result in 
Duchenne muscular dystrophy, and a 6-bp deletion also by a L1 insertion in the FCMD 
gene has been considered to cause Fukuyama-type congenital muscular dystrophy [60, 
61].  
 
6.2.2. Impact on splicing and gene expression 
 
In addition to the impact on genome structure, recent studies have shown that 
retrotransposons can also influence human evolution at the RNA level via various 
mechanisms [62-77]. Alternative splicing is a widespread phenomenon, which occurs in 
40-60% of human genes [2] and leads to human proteome variation by producing more 
than one type of mRNA from a single gene, encoding different proteins. Both Alu and L1 
elements can provide new splice sites, which can possibly contribute to exonization and 
alternative splicing [62, 63]. 
Research has demonstrated that RNA polymerase II has reduced ability to read 
through L1 sequences [64]. Therefore, intronic L1 elements can interfere with 
transcriptional elongation of the host gene. Additionally, gene transcript can be 
terminated by the polyadenylation signals carried by retrotransposons, which some time 
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leads to gene splitting [65-67]. 
Studies have shown that Alu elements are able to bind transcriptional factors, which 
might modulate gene expression [68, 69]. Evidence suggested that sense or anti-sense 
transcription through nearby genes can be triggered by the functional promoter of L1 and 
Alu elements [70, 71]. In addition, evidence also suggests that editing with Alu elements 
might be enhanced by their dimeric structure and certain intramolecular pairs of Alus, and 
A-to-I editing of pairs of opposite directional Alus in the 3’ UTR region can suppress 
expression through nuclear retention of mRNA transcripts [77]. 
 
6.3. Retrotransposon insertion polymorphisms (RIPs) 
 
Due to their continuing retrotransposition process, retrotransposons generate genetic 
diversity among species, as well as within species. Retrotransposon insertion 
polymorphisms (RIPs) can be defined as the co-existence of presence and absence status 
of a retrotransposon insertion at a specific site in a population of the same species. RIP 
represents an important type of genetic diversity due to the important impact of 
retrotranspsons on genome evolution and function as previous discussed, and therefore it 
is valuable to identify and document such type of genetic polymorphism in humans, 
along with other type of genetic polymorphism, such as SNPs and indels.    
 
6.3.1. Methods for identifying and ascertaining RIPs 
 
Many methods have been used to identify RIPs. Genomic library screening with RE 
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specific probes/primers has discovered a small number of RIPs in the early stage of the 
study on polymorphic retrotransposon insertions [78-80]. However, this can be very time 
consuming. The publication of the human genome reference sequence has allowed 
researchers to develop more fruitful methods. In the first strategy, retrotransposon 
elements belonging to young subfamilies were first identified as likely candidates for 
RIPs by computational sequence analysis, and oligonucleotide primers were then 
designed based on the flanking regions for polymerase chain reaction (PCR)-based assays 
to ascertain the polymorphism status of these candidates by screening DNA samples from 
diverse human populations[81-89]. While this strategy is straight forward and proven 
fruitful, leading to the identification of a total of 881 Alu, 392 L1, and 25 SVAs RIPs 
[26], the candidates are limited to those TEs that are contained in the reference genome 
sequence, and it is costly prohibitory to screen all young TEs.   
A second and more fruitful type of approaches is computational comparative 
genomics [90-96]. Wang et al. used the in silico comparative genomics approach at the 
whole genome level to identify Alu insertion polymorphisms in 2006 [90]. They 
compared the human genome sequences generated by the International Consortium of 
Human Genome Project with the version generated by the Venter group at Celera [2, 95]. 
A total of 800 Alu insertion polymorphisms were identified, which represented the largest 
data set of Alu insertion polymorphisms found by a single study at that time. These 
demonstrate that computational comparative genomics can be used as an efficient high-
throughput strategy for ascertaining RIPs. However, the lack of complete human genome 
data limited this method back then. 
Recently, a few more approaches have been developed for identifying de novo 
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retrotransposon insertions in individual genomes to utilize of next generation sequencing 
(NGS) technologies.  A few groups have been using NGS to selectively sequence the 
junction areas between RE insertions and their flanking region. For example, 
Witherspoon et al. identified 483 novel Alu RIPs from several Japanese individuals by 
using this strategy [97]. Similarly, Ewing & Kazazian utilized the NGS sequencing 
technology to identify novel L1 insertions. By surveying 26 individuals, they were able to 
identify 367 L1s outside the reference genome, the majority of which are novel 
polymorphic L1s [94]. Lately, with the availability of personal genome data in large 
numbers, such as those from the 1000 genome project, the computational comparative 
genomics approach has been adapted to make the use of these newly available genomes 
for identification of RIPs. For example, a total of 6209 novel RIPs were identified from 
the 1000 genome project [98, 99]. 
As the genome sequence data and the methods are not 100% accurate, validation of 
computational predictions are needed.  PCR is the current gold standard for ascertaining a 
RIP. The presence and absence of the RE insertion will lead to size difference at a 
specific locus: the size of the insertion positive allele will be larger than that of the 
insertion negative allele roughly by the size of the insertion. In this case, a pair of PCR 
primers based on the flanking region of the insertion can be designed. This method is 
good for REs with relatively small size and it can distinguish among the three genotypes 
of an RE insertion. Having only one large product means “+/+” and only one small 
product means “-/-” while having both the large product and the small product indicates 
“+/-” (Figure 4A). 
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However, it will be difficult to obtain a product of the insertion positive allele even 
with a long range PCR for a full length L1 and HERV as they can be as long as 10 kb. In 
this case, two additional primers inside the RE, which are oriented outwards, have to be 
designed. In the presence of the RE insertion, these two primers will work with the two 
primers in the flanking region to generate two shorter products, while for the insertion 
negative allele there is only one product from the two primers in the flanking regions. 
Similarly, the genotypes of the RE insertion can be determined.  Two larger products 
means “+/+” and one short product means “-/-” while having all three products stands for 
“+/-” situation (Figure 4B). 
The other advantage of the PCR assay is that it provides DNA for sequencing, so 
that the complete RE insertion sequence can be available. This is essential for RIPs 
outside the reference genome, since the RE insertion and TSD information are usually 
unavailable in such cases. Among the known RIPs, only a small portion has been PCR 
verified. Researchers tend to use it to assess the accuracy of the methods, as it might not 
be feasible to experimentally verify all RIP candidates due to their large numbers and 
prohibitive cost of validation by PCR. However, it important to experimentally validate 
all computationally identified RIPs as it will give more reliable and detailed genetic 
variation data, and it seems to be the solution to provide complete sequences for the RIPs 
determined by NGS based methods as they tended to give incomplete sequence 
information. 
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 Figure 4. Illustration of PCR as RIP ascertaining method.  
This figure was adopted and redrawn from Figure 1 in “Database documentation of retrotransposon 
insertion polymorphisms” by Liang P and Tang W [100]. Panel A: strategy for ascertaining a short RE 
insertions (e.g. <=2kb); Panel B: strategy for ascertaining a long RE insertions, such as full-length L1 and 
HERV insertions. 
 
6.3.2. Database documentation of RIPs in dbRIP 
 
Because of the large number of known RIPs and many more are expected to be 
identified, it is essential that these data are compiled in a way that is accurate and easy to 
access. Accuracy here refers not only to the reliability and accuracy of the data in all 
components of the information, including the sequence of the insertion, location, and 
classification, but also the completeness of the data. For example, just knowing the 
presence of the insertion at a specific location does not provide sufficient information 
about the potential impact of the insertion. It is important also to know the exact sequence 
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of the insertion, its orientation, and the TSDs or deletion of the flanking sequence and/or 
the presence of 5’ or 3’ transduced sequence. Other types of information, such as the 
source of the polymorphism (i.e. the specific population or individual showing the 
presence or absence of the insertion), the ascertaining/genotyping method, the insertion 
allele frequency in the examined populations, the phenotype association, etc. are also 
very useful.  The sample source is very important for future study of rare RIPs. Among 
the current databases covering RIP data, dbRIP is the only database which was designed 
specifically to accommodate the special needs of retrotransposon insertion polymorphism 
data [101]. Before this study, dbRIP contained a total of 2095 unique RIPs, among which 
are 1625 Alus, 407 L1s and 63 SVAs. 
 
6.4. Human specific retrotransposons  
 
As previously discussed, retrotransposon insertion polymorphisms are an important 
mechanism of generating both inter-species and intra-species diversity and 
retrotransposition events happened throughout the entire primate evolutionary history. 
There were retrotransposition events that happened after the divergence of humans and 
primates, therefore these retrotransposons were possessed by humans only. It would be 
valuable to identify these human specific retrotransposons and study their impact on the 
human genome. 
Previous studies on human specific retrotransposons (HS-REs) have either focused 
on identifying if a RE subfamily is human specific [79] or focused on testing human 
specific status for other results such as transduction [11]. In addition, most of the studies 
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have been limited by lack of resources: there were not enough primate genomes available 
at the time of their studies.  
 
Our hypothesis is that among the current REs in the human genome, a proportion 
of them arose from RE insertion events, which happened after the human and primate 
diverging and are human specific. These HS-REs have impacted human genome 
evolution and function by generating the genetic diversity between human and non-
human primates, as well as among human individuals. Therefore, this study was set to 
first develop a computational method to identify all HS-REs in the human genome by 
comparing the human genome with 4 other primate genomes, and then to analyze their 
trend, distribution and assess their impact on the evolution and function of the human 
genome. 
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7.Materials and methods  
 
7.1. Data collection 
 
7.1.1. Documenting reported RIPs 
 
In the first full release of dbRIP data in June of 2006[101], there were 2095 non-
redundant entries from a total 2897 reported cases, including 1625, 407 and 63 cases of 
Alus, L1s and SVAs, respectively, and later, the database was extended to include RIPs 
derived from HERVs. As part of this study, new RIPs reported in recent literature were 
collected with the sequences of the REs and their flanking region sequences (if available) 
were collected based on information from the original studies along with other detail 
information such as genotype, primer and so on. Then the RE was annotated to define the 
exact RE type, the exact start and end position of the RE insertions and TSDs. The 
sequence annotation was mostly done by RE-carrying allele sequences with 
corresponding pre-integration allele sequences using BLAT programs and in-house PERL 
scripts. A total of 1098 RIPs (803 Alus, 271 L1, 14 SVA, 10 HERVs) were collected and 
added to dbRIP from this study. In addition to data update, improvements and addition of 
utilities were made, and these include: i) the dbRIP was updated to support both hg18 and 
hg19; ii) a new dbRIP ID system was developed: a fixed length (7 digits) number was 
assigned to each unique entry with the 1st digit indicative of the TE type 
(1000000~1999999 for Alus; 2000000~2999999 for L1s; 3000000~3999999 for SVAs; 
4000000~4999999 for ERVs); iii) a new utility (Position Mapping) in dbRIP was 
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developed which allows researchers to easily check for overlaps between their RIPs result 
and RIPs in dbRIP; iv) the existing SearchdbRIP utility was upgraded to allow search by 
several new criteria; v) several existing errors were fixed and uniformed terminology was 
applied for several data fields.   
As of writing, dbRIP covers a total of 3,254 non-redundant RIP entries [100, 101], 
including 2569, 598, 77, 10 cases of Alus, L1s, SVAs, and HERVs, respectively (Table 1, 
collected from over 70 publications. The most updated RIP data were used as training and 
test data for methods used to identify HS-REs (see details in sections 7.2.4 and 8.2) 
 
7.1.2. Sources for genomic sequences 
 
The human genomic sequence data used in this study was the public version 
obtained from the University of California at Santa Cruz (UCSC) genomic website (Feb. 
2009 hg19, GRCh37) at http://genome.ucsc.edu, and the sequences of the chimpanzee 
genome (Oct. 2010 panTro3), the orangutan genome (Jul. 2007 ponAbe2) and the rhesus 
monkey genome (Jan. 2006 rheMac2) were obtained at the same site. The gorilla genome 
sequence was obtained from the Ensembl site at http://www.ensemble.org. The 
Repeatmasker file [102] for human genome (rmskRM327 for hg19) which contains all 
transposable element information was also downloaded from the UCSC genomic website. 
All DNA sequences in fasta format were downloaded onto local bioinformatics server for 
further analyses. 
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Table 1 dbRIP Statistics Release 2 (hg19) 
RIP 
Class 
# of loci 
(unique/total) 
# of loci 
outside 
hg19 
# of loci 
with 
genotype 
Loci in gene 
context 
(P/E/I/IG*) 
Disease- 
related loci 
Alu 2086/2708 858 526 5/7/23/735/1316 33 
L1 598/800 299 123 2/2/10/182/402 15 
SVA 77/87 18 31 1/1/4/28/43 3 
HERV 10/10 2 6 0/0/0/5/5 0 
Total 2771/3605 1177 686 8/10/37/950/1766 51 
*: D: downstream up to 1kb; P: promoter up to 1kb; E: exon; I: intron; IG: intergenic 
region; 
 
7.2. In silico identification of human specific retrotransposon elements 
 
Overview: A strategy was developed to identify all HS-REs in the human genome 
by comparing sequences at each of the REs in the human genome with the sequences at 
the corresponding (orthologous) region in the out-group genomes (i.e. the 4 non-primate 
genomes). Two main bioinformatics tools deployed in this strategy were BLAT and 
liftOver. RepeatMasker raw data was processed to generate an input list containing the 
chromosome coordinates of all RE candidates for the BLAT-based and a liftOver-based 
approach to identify HS-REs (the details of these two methods are provided in section 
7.2.2 and 7.2.3). The two lists of output from the two methods are then combined 
together to form the final HS-RE list. The selection of criteria for each of the two 
methods was determined based on a training dataset containing all RIPs documented in 
dbRIP, as described in section 7.2.4, and the accuracy and sensitivity of the approach was 
assessed by using a dataset containing novel RIPs identified by the 1000 genome project 
team[98]. 
Human-specific retrotransposon elements can be classified into two types based on 
the availability of orthologous regions of their flanking sequences in the out-group 
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genomes. Type I HS-REs have the pre-integration sequence available in out-group 
genomes (Figure 5A). Type II HS-REs have the entire region (insertion plus the specified 
minimal flanking sequences) missing in all out-group genomes (Figure 5B). 
 
 
Figure 5.  Screen shots of HS-REs in UCSC genome browser. 
Panel A: a typical Type I HS-RE. The red arrow points to an RE insertion, while the thin lines in all 
primates’ genomes indicate that the insertion is missing in all out-group genomes. Panel B: a typical Type 
II HS-RE. The RE labeled by the blue arrow has the insertion and flanking sequences missing in all out-
group genomes (thin lines in all out-group genome).  
 
7.2.1. Analysis and preparation of the raw data 
RepeatMasker is a program that screens DNA sequences for interspersed repeats and 
low complexity DNA sequences and it provides the only commonly accepted source for 
repeat sequences in the human genome. The Repeatmasker file (rmskRM327 for hg19) 
from UCSC genome website was used as input file. It contains detailed information of all 
transposable elements in the human genome such as chromosome coordinates, 
family/subfamily information and alignment against RE consensus sequence. Alu, L1, 
SVA and LTR retrotransposons were selected among all RE families as the focus of our 
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analysis, as they are known to have retrotransposition activities in the human genome. 
We also examined REs in L2 family and did not find any HS-REs (data not shown). We 
noticed that Repeatmasker reports as multiple individual entries for a RE that is 
interrupted by other sequence such as another RE insertion (see Figure 6 for an example), 
and a consolidation was performed necessarily for our purpose. RE fragments were 
grouped together and treated as one entry if they meet the following requirements: 1) they 
are in the same strand and belong to the same RE subfamily; 2) they are close to each 
other (with in 50kb); 3) they represent continuous sections on the RE consensus sequence. 
Also, since the Repeatmasker reports LTR and their internal elements separately, we 
grouped LTRs with their internal elements as one LTR entry. A unique ID was assigned 
to each RE after consolidation.  
We also looked into the events TE inserting into other TE. For fragmented REs 
which could be consolidated, we examined if there were TEs inside the gap. As shown in 
Figure 6, the AluSx would be considered as a TE inserting into TE events because the 
two adjacent AluJb could be consolidated. This was processed during the consolidation. 
More detail would be discussed in later section 8.1.1; 
 
Figure 6.  An example of a fragmented retrotransposon element. 
Two fragmented AluJb elements (indicated by the red arrows) belong to one complete AluJb, which was 
later interrupted by an AluSx insertion (indicated by the blue arrow). 
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 7.2.2. BLAT based method 
 
BLAST-like alignment tool (BLAT) [103] was developed specially to perform fast 
rapid mRNA/DNA and protein alignments at a high sequence similarity level.  In the 
BLAT based method for identifying HS-REs, DNA sequences representing the RE 
insertions and their flanking regions are retrieved from the human genome (hg19) based 
on the RE positions provided in the RE input file. Specifically, for each RE, we prepared 
and used three sequences as marker regions (Figure 7A).  Marker 1 consists of 50 bp 
sequences from each side the RE insertion joined together to represent the pre-integration 
site marker; Marker 2 consists of 50 bp from 5’ flanking region of the RE and 50 bp of 
the 5’ end of the RE to represent the 5’ junction area of the RE insertion. Marker 3 
consists of 50 bp of 3’ the RE and 50 bp of the 3’ flanking region to represent the 3’ 
junction area of the RE insertion. These three markers are identical in length at 100 bp. 
For each marker sequence, four BLAT runs were performed against the four out-group 
genomes. The match with the best score and sequence identity was selected among the 
four out-group genomes for that marker sequence. The advantage of using multiple out-
group genomes is discussed later in section 8.1.1.  
A total of four criteria were used for the BLAT based method: score, identity, 
coverage and span. The score equals the number of matches minus number of mis-
matches and the number of gaps in the target sequences (Score = match – mis-match – T 
gap count). A higher score means a better match. The identity is a percentage of the 
similarity between the query sequence and the target sequence. It is calculated as 100.0 * 
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(match + repeat match (Rep. match)) / (match + mismatch + Rep.match). Span and 
coverage are used to provide additional information about the match. Span is the total 
length of the target sequence (Span = Target end – Target start). Since BLAT tolerates 
gaps in the target sequence, it is able to report matches consisting of fragments with gaps 
in-between. So there is possibility that an entry could have both high score and identity 
while having a long gap in the target sequence. Similarly coverage is used to monitor the 
quality of match for the query sequence: Coverage = (Q end – Q start). 
If the BLAT result met all the following criteria: a minimum of score, identity, 
coverage and span length, a “+” sign was used to indicate that there is a positive match 
for the marker sequence in at least one of the out-group genomes. Otherwise a “-” sign 
was assigned to indicate the absence of the marker sequence at the corresponding region 
in all out-group genomes. The specific optimal criteria for determining a sequence match 
for each marker sequence, as well as a combinatorial criterion in evaluating all three 
markers were determined by utilizing a training dataset from dbRIP, the details of which 
are discussed later in section 7.2.4 and 8.2. In a perfect situation, a typical Type I HS-RE 
should have a combined pattern of  “+/-/-” for the three marker sequences in the order of 
“pre-integration site/5’ junction/3’ junction”, since if the retrotransposition insertion 
event happened after the human-chimpanzee separation, only the pre-integration site is 
present in the out-group genomes, while the two RE-flanking junction sequences will 
have only partial matches in these genomes (i.e., either to the flanking or RE, but not the 
two together at the same locus) . Similarly, a “-/-/-” pattern indicates a typical Type II 
HS-RE, in which the whole genome region is missing in the out-group genome. A typical 
 
39 
non HS-RE would have a pattern of “-/+/+”, since the RE is shared by human genome 
and at least one out-group genome.  
 
 
Figure 7. A schematic diagram of the in silico comparative genomics approach for 
identifying HS-REs  
Panel A: The BLAT-based method. The red box indicates the RE insertion while the two blue lines indicate 
the flanking sequences. Each arrow stands for 50 bp sequence; the two black arrows consist of the pre-
integration site, while the yellow arrows indicate the 5’ junction and the green ones stand for the 3’ junction. 
These sequences were later used for the BLAT based method as input data. Panel B: The liftOver-based 
method. The red box indicates the RE insertion while the two blue lines indicate flanking sequences. The 
green and yellow arrows, which are of 50 bp in length, stand for the chromosome coordinates of 5’ flanking 
and 3’ flanking regions, respectively. The black arrow indicates the start and end positions of the RE 
insertion. In the liftOver method, the chromosomal coordinates are used for finding a match in one of the 
four outgroup genomes.  
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7.2.3. liftOver based method 
 
LiftOver is a tool originally developed by the UCSC genome team 
(http://genome.ucsc.edu/cgi-bin/hgLiftOver) to allow conversion of genome coordinates 
between different assemblies of the same genome, but its use is also extended for finding 
corresponding/orthologous regions between genomes of closely related species.  The 
alignments between two genomes were constructed with BLASTZ, which is an 
independent implementation of the Gapped BLAST algorithm specifically designed for 
aligning two long genomic sequences [104]. These alignments were then chained 
together to form a chain file, which is a sequence of gapless aligned blocks, where for 
each region in the genome the alignments of the best quality were used. The resulting 
chain is used by liftOver to identify orthologous region between two genomes. 
For the liftOver based method, the position information of each RE was subtracted 
from the input file. The starting and ending positions of the 50 bp upstream flanking 
region, the RE region, and the 50 bp downstream flanking region were lifted onto each of 
the four out-group genomes (Figure 7B). Similar to the BLAT-based method, the best hit 
for each maker region among the four out-group genomes was used in the report of that 
RE.  A positive hit, which means the positions can be lifted onto an out-group genome, is 
marked as “+”, while a negative hit is marked as “-”. In this case, a Type I HS-RE is 
expected to have a pattern of “-/+/+” for the three regions in the order of 5’ flanking, RE, 
and 3’ flanking, while a typical non HS-REs is expected to have a pattern of “+/+/+”. 
Similar to BLAT-based method, a Type II HS-RE is expected to have a pattern of “-/-/-”. 
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The details on how to determine liftOver criteria would be discussed in section 7.2.4 and 
8.2. 
 
7.2.4. Determination of optimal BLAT and liftOver criteria for identifying HS-
REs 
 
The most challenging part of method development for identifying HS-REs is the 
determination of an optimal set of criteria for each of the method we used. Instead of 
using arbitrarily determined criteria, a training dataset containing RIP data in dbRIP was 
used. RIPs are results of recent retrotransposition events and show polymorphic status for 
its presence and absence in the human population. Therefore, human RIPs should be 
human specific, and it allows us to train our algorithms by checking the sensitivity of the 
method using criteria at different levels of stringency. A set of criteria is considered to be 
optimal when it generates a minimum accuracy of 95%. After the criteria for each method 
is determined, the BLAT and liftOver pattern for each RE can be obtained, and we 
classify all REs into four classes of REs based on the BLAT and liftOver patterns. 
Class I:  These REs are shown as Type I HS-REs supported by both BLAT and 
liftOver based methods with the match pattern being “+/-/-” and “-/+/+”, respectively. 
This class of HS-REs has the highest confident level due to the presence of a reliable pre-
integration site in the out-group genomes. Class II: These REs are shown as Type I HS-
RE by BLAT or liftOver based method but not both, thus the confidence level would be 
lower. Class III: These entries have a pattern of “-/-/-” (Type II HS-REs) by both BLAT 
and liftOver, and thus are HS-REs with a high level of confidence. Class IV: Similar to 
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Class II, these entries show a pattern of “-/-/-” entries by one of the two methods, and 
thus are HS-REs with a low level of confidence. We chose to leave out Class II and IV 
for better quality. 
In addition to typical Class I and typical Class III entries, there are non-canonical 
Class I and non-canonical Class III entries, which we name as Class Ib and Class IIIb, 
respectively. Class Ib entries are those that have one of its flanking sequences missing in 
the out-group genomes. For example, if an entry showed “+/-/-” for the BLAT based 
method and “-/+/-” for the liftOver based method, it would be listed as a Class Ib entry 
missing the 5’ flanking region. Similarly if a RE has a “-/-/+” pattern for both BLAT- and 
liftOver-based method, it is a ClassIb entry missing the 3’ flanking region.  These can 
happen if a HS-RE insertion occurred right next to another HS-RE, resulting the absence 
of a match for that side of flanking sequence in the out-group genome.  Class IIIb entries 
have a pattern of “+/-/-” pattern for the BLAT method and a pattern of “-/-/-” for the 
liftOver method, and this situation can happen if a HS-RE inserted into an HS-RE. In this 
case, despite the absence of a true orthologous pre-integration site in the out-group 
genomes, the BLAT search can find many high quality matches due to the presence of 
many sequences highly similar to the RE that was inserted into. More detailed discussion 
is provided later in section 8.3 and 9.1.2. Since Class Ib and IIIb represent legitimate HS-
REs by definition, we included them in our final list of HS_REs.  
HS-REs that involve transduction or insertion mediated deletion also have different 
BLAT and liftOver patterns from the canonical class I and III HS-REs. They are 
discussed separately in section 7.2.5 and section 7.2.6, since their identification requires 
additional steps of computational analysis. 
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 7.2.5. Transduction 
 
As previously discussed in section 6.2.1.2, the transduction events have known 
functional impact such as exon shuffling and disease association.  For a typical 3’ 
transduction event, the BLAT based method would return a “-/-/+” pattern and the 
liftOver based method would return a “-/+/-” pattern (Figure 8). For BLAT match, the 
pre-integration site marker would return a negative hit because of the presence of the 
transduced sequence in the human reference genome, while the 3’ junction marker 
sequence would return a positive hit because the combination of the particular RE and 
transduced sequence appear at a different location in the out-group genomes. The liftOver 
based method should be able to return a “+” for the 5’ flanking marker, therefore its 
pattern would be “-/+/-”. Similarly, a typical 5’ transduction event would have “-/+/-” for 
the BLAT pattern and “-/-/+” for the liftOver pattern.  However, these patterns may also 
be generated due to some other reasons. Therefore, entries with these BLAT and liftOver 
patterns were used as the candidates for HS-REs carrying transduction and subjected to 
further filtering processes. 
To identify HS-REs carrying transduction, it is necessary to determine the length of 
transduced sequence. An iterating search approach is used to identify the longest possible 
transduced sequence (Figure 9).  For example, for a 3’ transduction event, the 5’ flanking 
sequence was located in the human reference genome and retrieved, along with 50bp 
from the 3’ flanking (transduced sequence) was retrieved. The combination of two 
flanking sequences was then compared with the orthologous sequence retrieved from the 
 
44 
out-group genome to see if there was a positive match. If so, the entry would be stored for 
further validation, otherwise the script would continue down the 3’ flanking for another 
50bp until it reaches the arbitrary cutoff set at 20Kb. 
  To further validate the transduction, the flanking sequences and the transduced 
sequence retrieved from the human reference genome were compared against the 
orthologous sequences retrieved from the out-group genome again to identify the TSDs. 
Several BLAT runs were performed using a combination of the RE sequence and the 
transduced sequence against the human genome and the out-group genomes.  For an 
authentic HS-RE involving transduction, there should be one or more copies of junction 
marker sequence carrying transduction elsewhere in the human genome (one for the 
current insertion and one for the parent copy) and one copy in one or more of the out-
group genomes representing the parent RE.
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 Figure 8. A schematic diagram of the algorithm for identifying HS-RE with 3’ 
transductions 
Panel A: The BLAT-based method. The upper boxes indicate RE insertion in the human reference genome. 
The lower boxes indicate the orthologous regions in the out-group genomes. Red box indicates the RE 
insertion while the blue lines indicate flanking sequences and their orthologous regions in the out-group 
genome. The purple line indicates the transduced sequence. The BLAT run using the pre-integration site 
which was represented by the two black arrows would return a negative match as the two black arrows 
were quite distant. Similarly, the BLAT output for 5’ junction would be a “-” because the two yellow 
arrows are quite distant. However the BLAT run for 3’ junction would return a positive result because the 
RE and the transduced sequence were present at a different location in the genome. Panel B: The liftOver-
based method. The upper boxes indicate the RE insertion in the human reference genome while the lower 
boxes indicate the orthologous region the out-group genome. The red box indicates the RE insertion, the 
two blue lines indicate flanking sequences and the purple line stands for the transduced sequence. liftOver 
would only be able to find a positive match for the start and end position of the 5’ flanking sequences while 
the start and end positions of the RE and the 3’ flanking sequences were absent in the orthologous region in 
the out-group genome.  
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7.2.6. RE insertion mediated deletion 
 
The RE-insertion mediated deletion (RIMD) was also investigated in this study, as it 
has known functional impact to the human genome (previously discussed in section 
6.2.1.3). In such an event, instead of generating a TSD, the RE insertion causes the 
deletion of the region at the insertion site, leaving the apparent “pre-integration” site 
marker sequence without a full-length match in the out-group genomes. For this reason, 
in the case of a RIMD HS-RE, the BLAT based method would return a “-/-/-” pattern, 
because none of the three marker sequences will have a full-length match in the outgroup 
genomes (Figure 9). The liftOver based method would return a “-/+/+” pattern, as the two 
flanking regions have corresponding sequences in the out-group genomes despite of the 
deletion, but with a gap between the two matching regions at a distance equal to the 
length of the deletion, which ranges from 1bp to 70kb (previously discussed in section 
6.2.1.3).  
A looping strategy similar to the identification of transduction was used to identify 
the maximal length of deletion.  For each entry, the flanking sequences in human 
reference genome were located. The combination of two flanking sequences is then 
compared with the flanking sequence retrieved from the out-group genome to see if there 
is a positive match. If so, the entry would be stored for further validation, otherwise the 
script would continue to retrieve another 50bp until it reaches the arbitrary cutoff of 70Kb. 
To further validate the candidates from above step, the pre-integration site sequence 
retrieved from the human genome was compared against the orthologous sequences 
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retrieved in the out-group genome to look for evidence of TSDs. If there is a sign of 
TSDs, the entry would be considered as a false positive. 
 
7.2.7. Documentation of HS-REs in dbRIP 
 
HS-REs identified in this study have been deposited into dbRIP as a separate data 
set labeled using a special type of entry ID and a note. This data covers 6 different classes: 
Class I, Class Ib, Class III, Class IIIb, Transduction and RE insertion mediated deletion. 
RE sequence (labeled as red font in dbRIP) plus 400bp flanking sequence from each end 
(labled as blue font in dbRIP) are included. Additionally, for Class I, transduction and RE 
insertion mediated deletion entries, the orthologous sequences of the pre-integration site 
sequence in the out-group genomes is also provided and the available TSD sequences 
indicated in green color. The search utility in dbRIP has been modified to enable 
searching for HS-RE of any specific Class or subfamily.  
  
7.2.8. Computational scripts 
 
All computer procedures described in earlier sections were performed mostly using 
in-house computer scripts implemented in PERL (The Practical Extraction and 
Reporting Language), which was initially developed by Lary Wall in 1987[105].  A total 
of 609 scripts were developed for projects related to this thesis.  
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 Figure 9. A schematic diagram of in silico comparative genomics approach for 
identifying typical RE insertion mediated deletions. 
Panel A: The BLAT-based method. The upper boxes indicate RE insertion in the human reference genome. 
The lower boxes indicate the orthologous region in the out-group genomes. Red box indicates the RE 
insertion while the two blue lines indicate flanking sequences. The purple dashed line indicates the deleted 
sequence. The BLAT run using the pre-integration site sequence would return a negative match because of 
the deleted sequence between the two black arrows. Also BLAT results for the 5’ and 3’ junction would be 
“-” as well. Panel B: The liftOver-based method. The upper boxes indicate RE insertion in the human 
reference genome. The lower boxes indicate the orthologous region in the out-group genomes. The red box 
indicates the RE insertion while the two blue lines indicate flanking sequences. The dashed purple indicates 
the deleted sequence. The green and yellow arrows stand for the start and end positions of 5’ flanking and 3’ 
flanking, respectively. The black arrows stand for the start and end positions of the RE insertion. The 
liftOver based method would return a negative match for the insertion and positive matches for the 5’ and 3’ 
flanking. However, because the length of the deleted sequence was unknown, liftOver might only be able to 
locate one of the two flanking which gives a pattern of “-/+/-” or “-/-/+”. 
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8. Results 
8.1. Repeat masker input data 
 
REs that belong to the Alu, L1, SVA and LTR families were retrieved from the 
human genome reference sequence based on RE annotation by Repeatmasker, with each 
entry assigned with a unique ID after consolidation for fragmented REs, and they were 
used as the starting point for identification of human-specific REs. Specifically, a total of 
initial 2,774,171 RE entries were selected out of 5,298,130 of all TEs. The initial REs 
were consolidated into 2,132,960 complete and non-redundant entries. This list is used as 
input data for all downstream analyses.  
 
8.1.1. TE inserting into TEs 
 
All TEs reported by RepeatMasker were retrieved from the reference genome hg19. 
4,335,409 of all TEs were selected after consolidation, while 1290877(~30%) of them 
have inserted into anther TE comparing to 7739 HS-REs (~42%) have inserted into a TE. 
As previously discussed, TEs comprise ~45% of the human genome (Figure 1). 
Assuming TEs have equal chance inserting into TE region and non-TE region, there will 
be ~45% of the HS-RE inserted into a TE which is close to what we have observed. This   
suggests that HS-REs have no bias inserting into another TE. Assuming TEs in general 
have shared the same non-bias pattern, the ~30% of TE inserting into TE regions suggests 
that TEs comprises an average of ~30% of the human genome through the evolutionary 
history. Further analysis suggested that there is no TE family in particular is strongly 
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biased on inserting into TE regions except SVA (Table 2). SVA has a higher percentage 
of inserting into TE region because it is the newest RE family which originated ~25 My 
ago. DNA transposons which had lost their transposition abilities ~37 My ago, have the 
lowest percentage of inserting into TE regions. This suggests that at that time, TEs 
consisted of ~23% of the human genome. 
 
Table 2 percentage of TE inserting into TE region of major TE families 
Family TE inserting into TE region Total number Percentage 
 
DNA 87434 379846 23.0% 
LINE 259489 945612 27.4% 
LTR 153641 502748 30.6% 
SVA 1593 3530 45.1% 
SINE 527127 1692494 31.1% 
 
 
 
We then examine the host TEs to see if any TE families are strongly biased to be 
host TEs (Table 3). LINE is the most successful host TE Class as ~68% host TEs are 
LINE elements. Statistical analysis suggests that the success of LINE elements as host TE 
is contributed by its large size in the human genome: a Pearson correlation test was 
performed which suggested that the host TE number is significantly correlated to their 
size in the human genome hg19 (correlation coefficient = 0.8915; two tailed P value = 
0.0422; the correlation is significant). 
 
Table 3 Percentage of different HOST TE families  
Family Host TE number Total size in hg19(Mb) Percentage 
 
DNA 78493 98.4 6.97% 
LINE 765516 632.0 68.01% 
LTR 131927 264.4 11.72% 
SVA 93 4.0 0.01% 
SINE 149508 391.8 13.28% 
 
 
51 
 
 
8.2. Criteria determined by utilizing RIPs training dataset 
 
To determine the optimal criteria for our methods to identify HS-REs, a training 
dataset containing 2331 previously documented typical RIPs with complete sequence 
information in dbRIP database was used. The previously described BLAT and liftOver 
based methods were then applied to this training dataset. 
For individual RIPs, the 100 bp sequence of each of the three markers were obtained 
from dbRIP and were then used for BLAT against the four out-group genome. A sample 
BLAT output is shown in Table 4. The BLAT would align the query sequence and the 
target sequence and return all information related to the search such as numbers of 
matching and mismatching bases. It also indicates whether there is any gap in the 
alignment. Such information is used to determine the nature of the sequence match. 
Table 4. Sample BLAT output 
match mis-match 
Rep. 
match N's 
Q gap 
counts* 
Q gap 
bases 
T gap 
counts** 
T gap 
bases 
Q 
start 
Q 
end 
T 
start 
T 
end 
 
100 0 0 0 0 0 1 173 0 100 5536 5809 
98 2 0 0 0 0 2 174 0 100 3979 4253 
 
*Q: Query sequence was the 100bp sequences used for the BLAT input. 
**T: Target sequence was the targeted sequence BLAT found in the out-group genomes. 
 
A normal probability plot, which is a graphical technique to assess if a dataset is 
approximately normally distributed, was done for each criterion using all loci in the RIPs 
training set (Data not shown). Values which allow a 95% probability were selected. After 
manual adjustment, the optimal BLAT criteria were determined (Table 5).  The pre-
integration site had the lowest score cut-off as expected since the presence of TSDs (an 
extra copy of a small sequence) cause a gap for the alignment between Pre-integration 
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site sequence (a joint of the 5’ and 3’ flanking sequences) and the actual pre-integration 
site sequence from the out-group genomes. Also, the 3’ junction area had lower cut-offs 
than the 5’ junction because REs often have high mutation rate at the 3’ end (poly-A tail).  
 
Table 5. BLAT criteria based on the RIPs training dataset  
  score Identity coverage Span 
Pre-integration site 
Area 
76 92 92 110 
5’ Junction area 86 90 90 110 
3’ Junction area 82 90 85 110 
 
When these criteria were applied to the RIPs training dataset, 1722 Type I HS-RE 
and 501 Type II HS-RE were identified from the total 2331 entries (Table 6). The 
accuracy (sensitivity) is 2223/2331 or 95.4%. 
 
Table 6. BLAT output of the RIPs training dataset 
Pattern count 
+/-/-* 
-/-/-* 
-/-/+ 
-/+/- 
-/+/+ 
+/-/+ 
+/+/- 
+/+/+ 
1722** 
501** 
38 
17 
13 
17 
18 
5 
* Patterns indicate HS-RE 
** A sensitivity of 95.36% 
 
The liftOver based method was also applied to the RIPs test dataset. The liftOver 
utilizes a criterion called minMatch, which represents the minimum ratio of bases that 
must map on to the new genome. For example, if the minMatch ratio is set to be 0.5, 
liftOver would report a positive hit when 50% of the region can be mapped on to the new 
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genome. The positions of each of the three markers are collected from dbRIP and are then 
used for liftOver. The liftOver based method returns a sensitivity ratio of 95.8% when the 
minMatch ratio is set to be 0.1(Table 7). 
Table 7. liftOver output of the RIPs test dataset* 
Pattern number 
-/+/+** 
-/-/-** 
-/-/+ 
-/+/- 
+/+/+ 
2207*** 
26*** 
56 
40 
2 
* minMatch ratio of 0.1 
** Patterns indicate HS-REs 
*** A sensitivity of 95.6% 
Finally, the results from both methods were combined as previously described, i.e., a 
locus has to be called as positive for both methods using their respective parameters, and 
the resulted sensitivity for the RIPs test dataset was tested is 95.1%, providing an error 
rate slightly below the commonly accepted 5% (Table 8). Therefore, the criteria are 
appropriate for generating the HS-RE list. 
Table 8. Combined results of the RIPs test dataset 
RE Class number 
Class I* 
Class Ib* 
Class III* 
Class IIIb* 
Class II 
Class IV 
1698** 
504** 
14** 
5** 
103 
7 
* Class belongs to HS-REs 
** A sensitivity of 95.06% 
 
54 
8.3. Human-specific REs 
The 2,774,171 RE entries were processed using established optimal BLAT and 
liftOver criteria as described above and the results were shown in Table 9. We were able 
to identify 12156 typical Type I HS-RE and 12982 typical Type II HS-RE using the 
BLAT based method. As expected, the most common pattern for BLAT based result was 
“-/+/+” for shared REs, which was 87.1% of all REs. 28273 typical Type I HS-REs were 
identified by using the liftOver based method, which is significantly more than that of the 
BLAT based method. Also, the liftOver based results contained 5999 “-/-/+” and 5815 “-
/+/-” entries, which represent Type I HS-RE with one missing flanking. The liftOver 
based method was able to identify 7320 RE entries showing “-/-/-” pattern. Therefore, 
overall, the BLAT based method appeared to higher sensitivity, perhaps also higher false 
positive rate, in identifying the Type II HS-REs, while the liftOver based method seems 
to have better sensitivity for typical Type I HS-REs, but again perhaps also higher false 
positive here, since we do not have a method for ascertaining the identified HS-REs 
without performing bench experiments. 
Table 9. Match pattern for BLAT-based and lifeOver methods 
Pattern BLAT counts liftOver 
counts 
-/-/- 
-/-/+  
-/+/- 
-/+/+ 
+/-/- 
+/-/+ 
+/+/- 
+/+/+ 
12982** 
49054 
75389 
1859883 
12156* 
6897 
10960 
105639 
7320** 
5999*** 
5815*** 
28273* 
18 
3121 
3421 
2078993 
*: Typical Type I HS-RE 
**: Typical Type II HS-RE 
***: Type I HS-RE missing one flanking 
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To assess the reliability of these HS-RE candidates, we grouped then into 4 classes, 
depending whether they are supported by one or both methods as described in the related 
method section (7.2.4). Class I consists of entries showing the “+/-/-” pattern by BLAT 
and “-/+/+” by liftOver for Type I HS-REs in both methods. Class III contains entries 
showing “-/-/-” pattern in both methods. Some of the Type II HS-REs by BLAT based 
method may represent false positive as a result of high level of sequence divergence 
between the out-group genomes and the human genome. For example, the pre-integration 
site can be quite diverged due to SNPs, deletions, or most likely a nearby HS-RE 
insertion. In this case, the BLAT based method would probably have difficulty finding 
the match as it is based on similarity of the relative short sequence marker, therefore 
showing a “+/-/-” or “-/-/-” pattern. The liftOver based method works fine for this 
situation because it is based on the alignment of two genomes, so it would allow partial 
match by showing a “-/+/-” or “-/-/+” pattern. Therefore, the Class Ib would contain 
entries with incomplete pre-integration site information but are still supported as human 
specific by both methods (Table 10).  
Because of the abundance of RE elements in the human genome, there were many 
cases where an RE was inserted into another RE. For similar reasons, the BLAT based 
method would return a false positive pre-integration site marker because of the high 
sequence similarity (BLAT pattern “+/-/-”), while the liftOver would report it as typical 
Type II HS-REs (liftOver pattern “-/-/-”). Entries showing this pattern were labeled as 
Class IIIb.  
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Table 10. Combination of BLAT and liftOver results 
HS-RE Class BLAT result pattern liftOver result pattern Number of entries 
Class I* 
Class Ib*/*** 
Class Ib* 
Class Ib* 
Class Ib* 
Class Ib* 
Class III* 
Class IIIb* 
Class II  
Class II** 
Class II** 
Class II 
Class II 
Class II 
Class II 
Class II** 
Class II** 
Class II** 
Class II** 
Class II 
Class II 
Class II 
Class II 
Class II 
Class II 
Class II 
Class II 
Class II 
Class II 
Class IV 
Class IV 
Class IV 
Class IV 
Class IV 
Class IV 
Class IV 
Class IV 
Class IV 
Class IV 
+/-/- 
-/-/- 
-/-/- 
-/-/- 
+/-/- 
+/-/- 
-/-/- 
+/-/- 
-/+/+ 
-/+/- 
-/-/+ 
+/+/+ 
-/+/+ 
-/+/+ 
+/-/- 
-/-/+ 
-/-/+ 
-/+/- 
-/+/- 
+/+/- 
+/-/+ 
+/+/+ 
+/+/+ 
+/+/- 
+/-/+ 
+/+/- 
+/-/+ 
+/-/- 
+/-/- 
-/-/- 
-/+/+ 
-/-/+ 
-/+/- 
+/+/+ 
-/-/- 
-/-/- 
+/+/- 
+/-/+5 
-/-/- 
-/+/+ 
-/+/+ 
-/-/+ 
-/+/- 
-/+/- 
-/-/+ 
-/-/- 
-/-/- 
-/+/+ 
-/+/+ 
-/+/+ 
-/+/+ 
-/+/- 
-/-/+ 
+/+/+ 
-/-/+ 
-/+/- 
-/-/+ 
-/+/- 
-/+/+ 
-/+/+ 
-/+/- 
-/-/+ 
-/-/+ 
-/+/- 
-/+/- 
-/-/+ 
+/-/+ 
+/+/- 
+/+/+ 
-/-/- 
-/-/- 
-/-/- 
-/-/- 
+/-/+ 
+/+/- 
-/-/- 
-/-/- 
+/-/- 
10095 
2014 
1944 
1795 
333 
321 
1981 
265 
9254 
2094 
1885 
1591 
1217 
1183 
1077 
1040 
994 
952 
908 
800 
540 
256 
237 
172 
157 
155 
150 
33 
32 
4756 
2889 
736 
656 
527 
245 
236 
145 
121 
11 
*: Entries picked for final result list 
**: Entries picked as potential candidates for transduction event 
***: Entries picked as potential candidates for RE insertion mediated deletion. 
 
In total, 10095, 6252, 1981, and 265 entries were obtained for Class I, IIb, III, and 
IIIb, respectively (Table 10), making a grand total of 18593 entries as HS-RE candidates 
As a way to assess the accuracy of the result, a set of 779 novel RIPs generated from the 
1000 Genome Project [98], which are not currently included in dbRIP, are collected and 
cross-matched with the list of 18593 HS-RE candidates. 749 out of the 779 RIP entries 
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were covered by the HS-RE list, providing a sensitivity of 96.1%, which we think is 
satisfactory. 
 
8.4. Transduction 
 
7873 Class II entries with the previously discussed patterns were picked as potential 
candidates of transduction events.  Among there, 1885 entries showing “-/-/+” for BLAT 
and “-/+/+” for liftOver were selected as potential candidates for 3’ transduction, while 
2094 entries showing “-/+/-” and “-/+/+” were selected as potential candidates for 5’ 
transduction event. In addition, 3894 entries with non-typical patterns not matching above 
two patterns were selected (Table 10 entries labeled as **) in order to ensure best 
accuracy. After the 1st round process using the loop strategy, 3766 possible cases of 
transduction events were obtained, from which 1241 entries were retained after filtering 
with a bl2seq-based script. A final list of 112 transduction events was obtained after 
manual examination in the USC genome browser using BLAT. 
Among the final 112 entries, 38 (34%) are 5’ transduction events, while the 
remaining 74 (76%) are 3’ transduction events.  Therefore, the 3’ transduction event 
seems to be more common than the 5’ transduction. As previously discussed, the 
mechanisms differ between 5’ transduction and 3’ transduction: 3’ transduction is 
generated by a read-through transcription beyond the end of the RE element into the 
downstream region due to a weak termination signal within the RE, while 5’ transduction 
events are usually associated with external promoters upstream of the RE.  It is 
interesting to see that the ratio of the two transduction events differ significantly among 
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different REs.  L1s had more 3’ transduction events than 5’ transduction events with ~80% 
being 3’ transduction (Table 11). However, 5’ transduction events were more common in 
Alus and SVAs: 50% of the Alu transductions and ~43% of SVA transductions were 5’ 
transduction events. This may suggest that Alu and SVA have weaker internal promoters 
than L1, which means that Alu and SVA are more likely to be transcribed as a carry-on 
event of transcription involving external promoters located in their upstream regions. As 
previously mentioned in section 6.1.2 and 6.1.3, Alu and SVA are non-autonomous 
retrotransposons and have to hijack L1 machinery.  
The transduction events among HS-REs have contributed to the size increase of 
human genome. SVA is the most successful family in terms of size contribution via 
transduction which has transduced ~42kb of genomic sequences. In total, the 112 cases of 
transduction events have brought an increase of 71kb sequence in addition to the inserted 
RE sequence to the human genome. 
 
 
Table 11. Transduction events between different families 
Family 5’ transduction 5’ transduction 
size(bp) 
3’ transduction 3’ transduction 
size(bp) 
Alu 
L1 
SVA 
LTR 
Total 
11 
9 
17 
1 
38 
784 
3355 
21940 
1155 
27234 
11 
38 
23 
2 
74 
2136 
21513 
20006 
337 
43992 
 
RE elements have been reported to have the ability to impact human genome 
evolution through exon/gene shuffling mediated by transduction [106]. RE-mediated 
transduction inserted into intronic regions could possibly carry functional splice acceptor 
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sites, which could potentially lead to alternative splicing. Among the 112 cases, 27 cases 
have inserted into intron regions while the remaining 85 entries have inserted into 
intergenic regions (Table 12). 
 
Table 12. Genes involving HS-RE transduction in the intron regions 
Family Gene name Accession 
number 
NO. of intron 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
SVA 
Alu 
Alu 
Alu 
Alu 
CTNND2 
ETF1 
MAGI1 
OXR1 
TNRC6B 
GABBR2 
ENOX2 
KCNMB2 
VAPB 
MAP4 
PTPRA 
C11orf49 
ABHD6 
TTLL11 
ZAN 
CEP170L 
CASP8 
PDXDC2 
SNX8 
C5orf25 
CPA6 
ARFGEF1 
PTPN4 
AS3MT 
C1orf125 
CPNE4 
FAM135B 
NM:001332 
NM:004730 
NM:004742 
NM:018002 
NM:015088 
NM:005458 
NM:006375 
NM:005832 
NM:004738 
NM:002375 
NM:080841 
NM:001003676 
NM:020676 
NM:001139442 
NM:003386 
NR:003135 
NM:033355 
NR:003610 
NM:013321 
NM:198567 
NM:020361 
NM:006421 
NM:002830 
NM:020682 
NM:144696 
NM:130808 
NM:015912 
1/22 
2/11 
2/23 
2/16 
13/21 
7/19 
2/15 
1/6 
1/6 
1/19 
12/23 
3/8 
8/9 
6/9 
7/48 
2/8 
9/10 
1/26 
5/11 
3/9 
8/11 
1/39 
2/27 
9/11 
16/26 
1/16 
12/20 
 
 
8.5. RE-insertion mediated deletion 
 
2014 entries showing “-/-/-” pattern for BLAT and “-/+/+” for liftOver were picked 
as potential candidates for RE-insertion mediated deletion (Table 10 entries labeled as 
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***). After applying the loop strategy, 716 entries were filtered out and the remaining 
1298 entries were subjected to further validation, and finally 155 entries were identified 
as RIMD events by manual examination using BLAT within the UCSC genome browser. 
Among the 155 final RIMD entries, Alu contributed over 74 cases, close to 50% of 
all RIMDs (Table 13). Among the remaining 81 cases, 59 were for L1, and they 
contributed to the largest amount of deletion (~150kb). In total, the 155 entries deleted 
~270k of the genomic sequences.  
 
Table 13. RIMD events between different families 
Family Number of RIMD  Deletion size(bp) Average deletion 
Size (bp) 
  
Alu 
L1 
SVA 
LTR 
Total 
74 
59 
6 
16 
155 
76968 
149519 
13958 
27759 
268204 
1040 
2534 
2326 
1734 
1730 
  
 
 
As previously discussed, if the deleted target site DNA is located in genic regions, it 
might have potential to impact the function of the gene. Therefore, the locations of these 
RIMD entries were examined. Among the 155 entries, 37 cases had inserted into intron 
regions while the remaining 118 cases were in intergenic regions.  
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 Table 14. A list of genes carrying a RMID in intron regions 
Family Gene name Accession 
number 
NO. of intron Deletion Size(bp) 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
LTR 
SVA 
SVA 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
ELANE 
SRGAP1 
GPC6 
PTPN11 
MAML2 
PRKY 
ANAPC5 
ANKS1B 
THSD7A 
IMPG1 
HSD17B6 
RNU5D 
PDE7B 
MIB1 
FRMD5 
FANCA 
NFAT5 
EML5 
ERBB4 
TTBK2 
EYS 
CNTN5 
ANKS6 
TRIP12 
USP32 
STX8 
C10orf11 
DIS3L2 
SEMA3A 
SCARB1 
RYR2 
PCSK2 
CLEC16A 
GLCE 
CEP63 
UBE2G1 
GPC5 
NM:001972 
NM:020762 
NM:005708 
NM:002834 
NM:032427 
NR:028062 
NM:016237 
NM:152788 
NM:015204 
NM:001563 
NM:003725 
NR:002755 
NM:018945 
NM:020774 
NM:032892 
NM:000135 
NM:138714 
NM:183387 
NM:005235 
NM:173500 
NM:001142800 
NM:014361 
NM:173551 
NM:004238 
NM:032582 
NM:004853 
NM:032024 
NM:152383 
NM:006080 
NM:005505 
NM:001035 
NM:002594 
NM:015226 
NM:015554 
NM:025180 
NM:003342 
NM:004466 
3/5 
1/22 
2/9 
1/16 
2/5 
6/8 
15/17 
12/26 
6/27 
1/17 
3/5 
1/2 
2/13 
1/21 
1/14 
5/43 
2/16 
21/44 
20/28 
1/15 
26/43 
6/25 
6/15 
1/41 
27/34 
4/8 
4/6 
1/21 
4/17 
9/13 
10/105 
2/12 
11/23 
2/5 
2/16 
1/6 
7/8 
54 
1416 
40 
39 
25 
113 
10981 
3311 
42 
851 
5736 
15 
158 
667 
140 
313 
33 
2615 
788 
75 
381 
46 
40 
597 
27 
27 
80 
2674 
155 
35 
113 
1014 
30 
27 
299 
44 
900 
 
8.6. Final HS-RE list 
 
The transduction and RIMD entries were added to the final list, making a total of 
18860 HS-REs, and this is the list used for functional impact assessment.  Most of HS-
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REs were Class I and Ib entries with 10095 and 6252 entries, respectively (Table 15). 
Grouping of these HS-REs by the family allows us to examine the transposition activity 
level of different RE families (see more details in section 8.7.2). In addition to those from 
Alu, L1, and SVA, which are known to be highly active, we also found a large number of 
HS-LTRs. Among the total 783 HS-LTRs, 222 were full length entries, representing ~28% 
among all HS-LTRs, which is significantly higher than the 9.3% full-length entries 
among non-HS-LTRs, suggesting that the formation of solo-LTR occurs in a time-
dependent fashion.  
 
Table 15. Stats of final HS-RE list 
RE 
class 
Class I Class Ib Class 
III 
Class 
IIIb 
RIMD Transduction 
 
All HS-
RE 
Alu 8372 2160 887 149 74 22 11664 
L1 1239 2846 615 81 59 47 4887 
SVA 329 926 216 9 6 40 1526 
LTR* 155(34) 320(90) 263(87) 26(7) 16(3) 3(1) 783(222) 
Total 10095 6252 1981 265 155 112 18860 
*: total number (full length entry number) 
 
 
8.7. Functional impact assessment 
8.7.1. TSD length and integration site sequence motif 
The TSD is the hallmark of an RE insertion event. It also represents a type of 
genomic variation generated by RE-insertion in addition to the RE insertion itself, and its 
sequence pattern reflects the retrotransposition mechanism involved. The pre-integration 
site sequence for the 10095 Class I entries were retrieved from the out-group genomes 
and used to compare with the corresponding human sequences. By utilizing a 
BLAST2sequence tool (bl2seq), we were able to identify TSDs for 9222 entries. 
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The average lengths of the TSD were examined as it is an important characteristic of 
RE insertion (Table 16). Alu family had the longest average TSD length at 18.7bp with 
standard deviation being 14.8 bp, while L1 and SVA have similar length of TSD at 
15.5bp and 16.4bp, respectively. The LTR had the shortest TSD pattern among all 
families, only 8.6bp on average. Although not significant, the average TSD length does 
seem to have a weak negative correlation with the average RE length of the RE family 
(correlation coefficient is -0.19; one tailed P value = 0.4041). 
 
Table 16. Average length of TSD of each RE family 
Type Copy 
number 
Average 
TSD 
length(bp) 
Standard 
deviation(bp) 
Average RE 
length(bp) 
HS-Alu 7723 18.7 14.8 312.2 
HS-L1 1061 15.5 9.8 6146.8 
HS-
SVA 
305 16.4 6.9 1383.8 
Hs-
LTR 
133 8.6 5.8 2272.6 
HS-RE 9222 18.1 14.1 1047.2 
 
Overall, HS-Alu, HS-L1 and HS-SVA have TSD length around 16 bp. This confirms 
the existing theory that Alu and SVA hijack L1’s machinery for retrotransposition, and so 
they share the same mechanism for transposition. While the utilization of Alu 
transposition via L1 machinery seems to be supported by experimental data, the use of L1 
machinery for SVA transposition is purely hypothetical so far. Therefore, our data here 
provides the first evidence supporting this hypothesis.  The fact that LTRs have 
significantly shorter TSD length than the three non-LTR families (Table 17) agrees with 
 
64 
the fact that LTRs use a different retrotransposition mechanism and the hypothesis that 
the pattern of TSD (length and sequence characteristics) is determined by the 
retrotransposition mechanism.   
       
Table 17. Z-test results of average TSD lengths of different RE families 
2-tailed P 
value 
HS-Alu HS-L1 HS-SVA HS-LTR 
HS-Alu 1 < 0.0001 0.0002 < 0.0001 
HS-L1 < 0.0001 1 0.0699 < 0.0001 
HS-SVA 0.0002 0.0699 1 < 0.0001 
HS-LTR < 0.0001 < 0.0001 < 0.0001 1 
 
We also examined and compared the sequence motif of the integration sites among 
different RE families by taking the 15bp sequence on each side of insertion sites. The 
HS-Alu, HS-L1 and HS-Alu show tt-AAAA pattern at the nick site, which agrees with 
results from previous studies [90](Figure 10). However, our data suggested that there is a 
low but evident bias on the 7th and 8th bp for “A”, and this extends the nick site pattern to 
“tt-AAAAAA”.  The HS-LTR, however, did not show a visible motif at the nick site, and 
this further proves that Alu, SVA and L1 share the same machinery while LTRs utilize a 
different machinery for retrotransposition.  
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  Figure 10. Base composition of insertion motif for different HS-RE families.  
Sequence logo generated by using the weblogo tool 
(http://weblogo.berkeley.edu/logo.cgi). The numbers on the x-axis indicate the base 
position starting from the 15th base on the 5’ side of the pre-integration site. The height of 
the base letter indicates the frequency of the most dominant base at the position. 
 
8.7.2. Retrotransposition activity of HS-RE subfamilies 
 
The availability of a complete set of HS-REs allowed us to provide an accurate 
assessment of the activity of RE families in the human genome. For this, we use the 
human-specific ratio (HS-ratio), which is defined as the ratio between the number of  HS-
REs and the total number of members for a subfamily in the human genome sequences 
(Table 18). Since HS-REs are products of recent retrotransposition events, having a 
higher HS-ratio means there are more members relatively contributed by recent 
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retrotransposition events.  Therefore, we used the HS-ratio as an indicator for the activity 
level of different RE families.  
 
Table 18. Subfamily distribution of different HS-RE families 
Class Family Subfamily Total copy 
number in 
hg19 
Copy number 
of HS-REs 
HS-ratio* size 
contribution 
(kb) 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
SINE 
 
LINE 
LINE 
LINE 
LINE 
LINE 
LINE 
LINE 
LINE 
LINE 
LINE 
LINE 
LINE 
 
Other 
Other 
Other 
Other 
Other 
Other 
 
LTR 
LTR 
LTR 
LTR 
LTR 
 
 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
Alu 
  
L1 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
L1 
 
Other 
Other 
Other 
Other 
Other 
Other 
 
LTR 
LTR 
LTR 
LTR 
LTR 
 
 
AluYa5 
AluYb8 
AluYb9 
AluYd8 
AluYg6 
AluYk12 
AluYa8 
AluYf4 
AluYc5 
AluYh9 
AluYk11 
AluYc3 
AluYc 
AluYk4 
AluY 
AluYf5 
All Alu 
L1HS 
L1PA2 
HAL1-2a_MD 
L1P1 
HAL1-3A_ME 
L1PA3 
L1P4e 
L1M4b 
L1P2 
L1P3b 
L1M2a1 
L1MA5 
All L1 
SVA_E 
SVA_D 
SVA_F 
SVA_C 
SVA_B 
SVA_A 
All SVA 
ERVK 
ERV1 
ERVL 
ERVL-MaLR 
Gypsy 
All LTR 
All RE 
3857 
2820 
327 
225 
784 
212 
325 
1347 
45 
265 
1026 
567 
8268 
1839 
117010 
180 
1083462 
1484 
4699 
1281 
2869 
1824 
10072 
121 
2412 
1245 
65 
72 
2609 
546108 
226 
1329 
986 
278 
458 
253 
3530 
7351 
107223 
109629 
257325 
8356 
499860 
2132960 
3218 
2279 
258 
151 
386 
80 
118 
298 
6 
29 
83 
41 
257 
41 
2446 
3 
11664 
1135 
1977 
197 
209 
103 
348 
3 
49 
21 
1 
1 
26 
4887 
155 
817 
494 
33 
20 
7 
1526 
218 
344 
103 
115 
3 
783 
18860 
83% 
81% 
79% 
67% 
49% 
38% 
36% 
22% 
13% 
11% 
8% 
7% 
3% 
2% 
2% 
2% 
1% 
76% 
42% 
15% 
7% 
6% 
3% 
2% 
2% 
2% 
2% 
1% 
1% 
1% 
69% 
61% 
50% 
12% 
4% 
3% 
43% 
3% 
0% 
0% 
0% 
0% 
0% 
1% 
996.4  
710.8  
72.1  
44.8  
119.3  
23.0  
23.0  
92.3  
1.6  
8.1  
23.1  
12.2  
39.0  
12.1  
729.0  
1.0  
3377.4  
2574.4  
3811.6  
37.3  
148.9  
11.9  
676.8  
0.2  
25.2  
9.0  
0.6  
0.1  
4.3  
7653.7  
176.6  
1142.9  
506.6  
43.4  
25.7  
8.9  
1904.1  
420.9  
663.5  
51.9  
11.9  
0.2  
1148.4  
14083.6 
*Subfamilies with HS-RE ratio >= 1% are listed except HS-LTR, for which anything above 0% are listed. 
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Most of the HS-REs belong to the Alu family and a lot of those HS-Alus are within 
the AluY linage. This made HS-Alu the most successful and active RE family in terms of 
copy number. Our data confirms the previous observations that Ya5 and Yb8 are very 
active Alu subfamilies within the human lineage (83.43% and 80.82% HS-ratio), while 
Yb9 and Yd8 are also very active having 78.90% and 67.11% as HS-ratio. Additionally, 
Alu subfamilies Yg6, Yk12, Ya8, Yf4 and Yc5 have higher retrotransposition activity 
than average.  
Most of L1 subfamilies have very low level of activity while the L1HS, L1PA2 and 
HAL1-2a_MD subfamilies seem to have maintained a significant level of 
retrotransposition activity as their HS-ratio are close to most of Alu and SVA subfamilies. 
L1s are the most successful HS-REs in terms of size contribution (Figure 12). 
As previously reported, SVA subfamilies are very active. Overall, it has higher 
activity among all HS-RE families. Among the 6 subfamilies, SVA_D, SVA_E and 
SVA_F have a significant higher level of activity than the rest. This agrees with the fact 
that they are the newest group of REs in the human genome [26].  
The LTR family has the lowest activity level as expected. Our data confirm the 
previous observation that the HERV-K subfamily is the only current active LTR 
subfamily [107] as it has significant higher HS-ratio, more than 10 times higher than the 
rest of LTR subfamilies. This might indicate that the current activity of HERV-K 
subfamily has been underestimated: the HERV-K subfamily had a 2.97% HS-ratio which 
was higher than the AluY family.   
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 Figure 11. Subfamily distribution of HS-RE. 
The x-axis indicates different RE subfamilies; The left y-axis indicates HS-ratio in percentage; The right y-
axis indicates RE copy numbers in human genome hg19 and their size contribution (kb); Purple bars stand 
for HS-ratio for each RE subfamily; Blue line indicates copy number for each HS-RE subfamily; Yellow 
line indicates total size contribution of each HS-RE subfamily; Blue arrow indicates the peak of copy 
numbers of HS-REs in the human genome; Yellow arrow indicates the peak of size contribution of  HS-L1 
in the human genome; Purple arrow indicates the highest overall  
  
8.7.3. Distribution of HS-REs throughout the human genome 
The distribution pattern of HS-REs throughout the human genome was examined to 
check whether there is any bias for specific chromosomes, the relationship between gene 
density and RE density, and the relationship with HS-REs and shared REs.  By analyzing 
the RE density data and gene density data, we were able to identify the relationship 
between RE density and gene density within each RE family (Table 19). The result of 
Pearson correlation test suggests that HS-Alu density is positively related to gene density, 
but the correlation is not significant (correlation coefficient= 0.07; the two tailed P value 
= 0.7402). Shared Alu density is significantly related to gene density (correlation 
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coefficient= 0.95; two tailed P value < 0.0001).  HS-L1 density show a negative 
correlation with gene density but the correlations is insignificant (correlation coefficient 
= -0.13; two tailed P vale = 0.5392). The shared L1 density is negatively correlated to 
gene density while the correlation appears to be significant (correlation coefficient= - 
0.48; two tailed P vale = 0.0146). The HS-SVA density and shared SVA density are 
significantly correlated to the gene density with a correlation coefficient of 0.83 (two 
tailed P value <0.0001) and 0.95 (two tailed P value <0.0001), respectively. HS-LTR 
density is showing an insignificant negative correlation with gene density while shared 
LTR density is showing a significant negative correlation with gene density (correlation 
coefficient = -0.05 and -0.44, two tailed P value = 0.8038 and 0.0296, respectively). 
 
Table 19. RE and gene density in the human genome 
Chromosome Gene 
density 
(per 
Mb) 
Alu density (per 
Mb) 
L1 density (per 
500Kb) 
SVA density (per 
100Kb) 
LTR density (per 
100Kb) 
HS-Alu Shared 
Alu 
HS-L1 Shared 
L1 
HS-
SVA 
Shared 
SVA 
HS-
LTR  
Shared 
LTR 
chr1 
chr2 
chr3 
chr4 
chr5 
chr6 
chr7 
chr8 
chr9 
chr10 
chr11 
chr12 
chr13 
chr14 
chr15 
chr16 
chr17 
chr18 
chr19 
chr20 
chr21 
chr22 
chrX 
chrY 
Whole 
genome 
14.8 
8.4 
9.2 
6.5 
8.0 
10.0 
10.2 
8.4 
10.4 
10.4 
15.3 
12.7 
5.7 
12.3 
13.8 
16.3 
24.4 
6.1 
40.9 
15.4 
12.2 
21.9 
12.1 
9.9 
11.7 
3.8 
3.7 
3.8 
3.7 
3.8 
3.6 
3.6 
3.4 
4.2 
3.3 
3.7 
3.7 
4.0 
3.5 
3.7 
4.3 
4.6 
3.7 
8.0 
3.7 
3.5 
4.1 
4.4 
27.3 
4.1 
414.2 
322.8 
314.7 
268.2 
296.1 
319.5 
413.2 
316.4 
374.3 
392.4 
336.4 
414.1 
277.5 
376.3 
433.7 
587.6 
669.3 
301.1 
930.3 
443.5 
330.6 
635.8 
286.2 
327.1 
374.6 
2.7 
3.4 
3.1 
4.2 
3.6 
3.1 
3.0 
3.2 
2.7 
2.4 
3.4 
3.1 
2.9 
2.9 
2.5 
2.6 
1.8 
3.4 
2.9 
3.1 
2.6 
3.3 
5.5 
26.0 
3.4 
335.5 
378.2 
381.3 
373.3 
382.3 
374.8 
384.2 
377.0 
393.3 
375.3 
359.2 
359.4 
394.8 
365.4 
390.8 
357.7 
332.8 
385.2 
327.6 
379.8 
379.8 
313.7 
512.8 
398.6 
378.3 
7.1 
5.1 
5.4 
3.7 
4.6 
5.3 
5.6 
3.8 
5.8 
4.8 
5.4 
5.2 
3.8 
5.3 
5.0 
5.3 
9.1 
2.8 
12.0 
8.9 
2.0 
10.0 
4.2 
1.6 
5.3 
8.5 
6.5 
6.1 
5.4 
6.4 
5.9 
6.9 
5.5 
7.8 
6.9 
7.5 
7.3 
4.4 
7.8 
7.8 
7.0 
10.4 
5.9 
15.2 
7.6 
5.7 
9.5 
7.3 
4.7 
7.0 
1.2 
0.9 
1.4 
1.0 
1.5 
1.6 
0.9 
1.5 
1.6 
1.2 
2.0 
2.0 
1.7 
1.4 
1.8 
1.5 
2.2 
1.1 
6.5 
0.8 
1.7 
2.9 
3.9 
123.2 
2.7 
161.0 
173.6 
176.7 
200.1 
183.6 
170.2 
167.6 
186.1 
171.7 
164.1 
161.3 
176.4 
192.0 
178.1 
147.5 
179.4 
134.3 
177.5 
161.9 
201.3 
229.7 
142.1 
178.5 
172.1 
174.4 
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 When the density of HS-REs and shared REs are compared among chromosomes 
(Figure 12), it is interesting to see that HS-Alu, HS-L1, and HS-LTR all have their 
density peaks at chromosome Y, which are much higher than other chromosomes.  More 
interestingly, it seems from the graph that the HS-Alu density and HS-LTR density are 
correlated to gene density except at chromosome Y even though previous Pearson 
correlation tests suggest otherwise. Therefore, another set of Pearson correlation tests 
were done by excluding the data from chromosome Y.  By these tests, HS-Alu density is 
showing a significant correlation with gene density (correlation coefficient = 0.85; the 
two tailed P value <0.0001). The HS-LTR is showing a significant correlation with gene 
density (correlation coefficient = 0.79; the two tailed P value <0.0001), while correlation 
level did not change for the rest comparisons. The unusual high density of HS-REs in Y 
chromosome in unexpected, and we suspect that it may be due to a higher rate of false 
positive as a result of insufficient sequence data for Y chromosomes in the other primate 
genomes. The fact a higher ratio of type II HS-REs is seen in Chromosome Y than in 
other chromosomes is also an indication for this possibility.  
We also suspect that the gap on chimpanzee chromosome Y, which is the only 
available out-group chromosome Y, is the reason for high numbers of Type II HS-RE on 
the human chromosome Y. If a RE is located within the homologous regions of such gap 
regions on the human chromosome Y, it would be reported as a Type II HS-RE which 
could potentially be false positive. In order to find out how many Type II HS-REs were 
contributed by those gap region, we identified the homologous regions of those gap 
regions on the human Y chromosome by using liftOver. Surprisingly, none of our 
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identified HS-REs are located within these homologous regions. This suggests that 
chromosome Y bias of HS-REs might be valid.  
 
Figure 12. The density of HS-REs and genes in the human chromosomes.  
The y axis indicates the RE and gene density. The x axis indicates different chromosomes. 
 
8.7.4. GC content for different HS-RE families and all other members in the 
same families 
Based on previous studies, L1s tend to insert into GC-poor region and Alus tend to 
insert into GC-rich region [108]. So, it would be interesting to find out if HS-REs share 
the same pattern with the older RE members in their families. Different sizes of the 
flanking region were tested to find out the optimal cut-off. According to the results, 
1500bp from both upstream and downstream of the RE insertions were used for 
calculating the GC-content (Table 20).  
Table 20. GC-content data of different HS-RE families and older members in the 
RE family 
 HS-RE Older RE 
   Copy 
numbers 
GC content     Standard 
deviation 
Copy 
number  
GC content     Standard 
deviation 
Alu 11664 40.5% 6.1% 1071798 42.1% 5.8% 
L1 4887 38.4% 5.4% 541221 39.0% 5.4% 
SVA 1526 45.9% 8.1% 2004 44.9% 8.1% 
LTR 783 41.6% 6.5% 499077 40.3% 5.6% 
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All RE 18860 40.5% 6.4% 2114100 40.8% 5.7% 
 
Z-test was performed to test if the patterns of GC-content of different HS-RE 
families are significantly different from each other, as well as from older members in 
their families (Table 21). The results indicate that each HS-RE family has a unique GC-
content pattern when comparing to older members in the family. Also, the GC-content 
pattern for each HS-RE family is significantly different than other HS-RE families. HS-
Alu and HS-L1 have lower GC-content than the older REs in their families, while HS-
SVA and HS-LTR have higher GC-content than their older counterparts. Among the four 
HS-RE families, HS-SVA has the highest GC-content, while HS-L1 has the lowest GC-
content.  
 
Table 21. Z-tests result for different HS-RE families 
2-tailed p value HS-Alu HS-L1 HS-SVA HS-LTR 
Older RE < 0.0001 < 0.0001 0.0003 < 0.0001 
HS-Alu 
HS-L1 
HS-SVA 
HS-LTR 
1 
< 0.0001 
< 0.0001 
< 0.0001 
< 0.0001 
1 
< 0.0001 
< 0.0001 
< 0.0001 
< 0.0001 
1 
< 0.0001 
< 0.0001 
< 0.0001 
< 0.0001 
1 
 
   
8.7.5. Genome size contribution by human-specific retrotransposons 
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Genome size is a property characteristic of a species. Transposable elements are a 
major factor impacting the genome size. Here, we examined the impact of HS-REs on the 
human genome size with breakdowns into individual chromosomes (Table 22). In total, 
the HS-REs have contributed to ~ 14 Mb size increases, which represent ~0.49% of the 
entire human genome. T-test indicates that the overall size increased ratios of most 
chromosomes are not so different from the size increased ratio of the whole genome. Yet 
the size increase ratio of the chromosome Y is significantly larger than that of the other 
chromosomes (5.36% compare to a whole genome average of 0.49), and this was mostly 
contributed by HS-LTRs and HS-Alus as previously described. Interestingly, HS-LTR on 
chromosome Y has contributed to a 725.6kb increases which consists of ~63.2% of its 
total contribution to the whole genome. 
Based on our result, it could be concluded that because of the bias of HS-RE (which 
would later be discussed in section 9.2.2), chromosome Y is receiving significantly more 
size increase than chromosome X and autosomes: a one tailed one sample T test is 
performed utilizing increase size ratio data (Table 22). The null hypothesis is that the 
average size increase ratio in the human genome is significantly smaller than the size 
increase ratio on chromosome Y. Based on the T test result (one tailed P value< 0.0001; 
alpha = 0.05), we failed to reject the null hypothesis. This proves that chromosome Y has 
significantly higher size increase ratio than any other chromosomes in the human genome.  
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Table 22. Size contribution by HS-RE on different chromosomes 
Chr Non gap length(Mb) Total size increase by 
HS-RE(kb) 
Increased size ratio % 
chr1 225.3 1040.0 0.46 
chr2 238.2 1108.4 0.47 
chr3 194.8 1002.8 0.51 
chr4 187.7 983.2 0.52 
chr5 177.7 864.4 0.49 
chr6 167.4 710.8 0.42 
chr7 155.4 622.9 0.40 
chr8 142.9 588.3 0.41 
chr9 120.1 460.8 0.38 
chr10 131.3 461.2 0.35 
chr11 131.1 611.8 0.47 
chr12 130.5 556.7 0.43 
chr13 95.6 406.2 0.42 
chr14 88.3 391.5 0.44 
chr15 81.7 294.6 0.36 
chr16 78.9 284.9 0.36 
chr17 77.8 291.7 0.37 
chr18 74.7 346.4 0.46 
chr19 55.8 313.4 0.56 
chr20 59.5 250.1 0.42 
chr21 35.1 109.6 0.31 
chr22 34.9 136.8 0.39 
chrX 151.1 872.7 0.58 
chrY 25.7 1374.5 5.36 
Whole genome 2861.3 14083.6 0.49 
 
 
8.7.6. Gene context of human specific retrotransposons elements 
 
As a way of assessing the potential impact of HS-REs, we examined their 
distribution in relation to genes by categorizing them into different genic regions. While 
most of HS-REs have inserted into intron and intergenic region, there are 85 of them have 
inserted into exon and promoter regions (Table 23). This suggests that HS-REs have 
potential impact on gene expression in the human genome. 
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Table 23. Gene context information of different RE families 
 
Family 
Gene context loci  
exon promoter downstream intron  intergenic 
Alu** 25/4586 36/46 26/4223 4150/486227 7427/609437 
L1 8/1986 4/2493 6/1319 1342/307310 3527/620489 
SVA 5/6 3/6 4/4 606/751 908/1315 
LTR 1/1520 3/1743 0/1196 114/134808 665/463452 
All RE 39/8098 46/11852 36/6742 6212/929096 12527/1694693 
*: downstream up to 1kb; promoter up to 1kb; 
**: HS-RE/non HS-RE 
 
The genes with HS-RE insertions in their exon regions are investigated individually 
(Table 24). Among the 39 cases, 3 REs inserted into coding sequences (CDS); 2 REs 
inserted into 5’ untranslated region (5’ UTR); 31 cases have inserted into 3’ UTR region 
while the rest 3 REs have inserted into non-coding region.  
As previously discussed in section 6.2.2, many REs contain in their sequences the 
binding sites for transcriptional factors, thus HS-REs in the promoter regions can have 
the potential to alter gene expression by creating new sites for transcriptional factors, 
aside from interrupting existing transcription factor binding sites by insertions. REs 
inserted into 3’ UTR region can down regulate gene expression. For example, A-to-I 
editing of pairs of opposite directional Alus in the 3’ UTR region can suppress expression 
through nuclear retention of mRNA transcripts [77]. In the case of BBS5, a gene 
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encoding a protein that has been directly linked to Bardet-Biedl syndrome, an HS-SVA 
inserted at the end of last exon forms a long 3’ UTR region that is unique to human.  
 
Table 24. A list of genes containing HS-REs in exon regions 
Region of 
insertion 
Official 
Gene 
Symbol 
Inserted RE type Accession  
Number 
CDS 
CDS 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
3UTR 
5UTR 
5UTR 
NC 
NC 
OVCH2 
RPGR 
AAK1 
ABCC9 
BBS5 
BCDIN3D 
C5orf36 
CCDC122 
DNAJC21 
DSG3 
FAM119A 
FAM119A 
FOXK1 
GBP4 
GNB5 
HIST2H2BF 
IGFL4 
KIAA0101 
KIAA0319L 
LRRC58 
MBOAT1 
NEK5 
OPHN1 
PDDC1 
RAB21 
RAB3B 
SEMA3E 
SLC13A1 
TBC1D15 
UTP11L 
WIPF2 
ZNF543 
CHRM3 
TRIB3 
C14orf23 
OR6W1P 
AluYa5 
HAL1-3A_ME 
L1PA3 
L1PA2 
SVA_D 
AluYa5 
AluYb8 
AluYb8 
AluYa5 
AluYb8 
SVA_E 
SVA_E 
AluY 
AluYg6 
AluYc3 
AluYa5 
L1PA2 
AluYb8 
AluSc8 
AluY 
AluYa5 
SVA_D 
L1HS 
MLT1A0 
AluY 
AluYb8 
AluYb9 
AluYa8 
AluYa5 
AluYb8 
AluYc 
AluYa5 
L1HS 
AluY 
AluYb8 
SVA_E 
NM_198185 
NM_001034853 
NM_014911 
NM_020297 
NM_152384 
NM_181708 
NM_001145678 
NM_144974 
NM_194283 
NM_001944 
NM_001127395 
NM_001127395 
NM_001037165 
NM_052941 
NM_016194 
NM_001024599 
NM_001002923 
NM_014736 
NM_024874 
NM_001099678 
NM_001080480 
NM_199289 
NM_002547 
NM_182612 
NM_014999 
NM_002867 
NM_012431 
NM_022444 
NM_022771 
NM_016037 
NM_133264 
NM_213598 
NM_000740 
NM_021158 
NR_026731 
NR_002140 
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9. Discussion  
9.1. In silico identification of human specific retrotransposon elements  
In this study, we have presented a comparison between the human genome and four 
other primate genomes towards identifying and characterizing human specific RE 
insertions. The computational approach used in this study represents an efficient and 
accurate method to identify all HS-REs in the human genome. In our study, a total of four 
out-group genomes were used to ensure maximum accuracy. Furthermore, two different 
computational tools were used, and the methods were trained with known RIPs in dbRIP 
and their sensitivity validated using novel RIPs outside dbRIP. In total, 18860 or ~0.9% 
of all RE elements in the human genome were conservatively identified as human 
specific. Our study represents the most comprehensive analysis of human specific 
retrotransposons to date, providing new insights on the degree of retrotransposition in the 
human genome and the impact on genome evolution and function 
 
9.1.1. Value of using four additional primate genomes in identifying HS-REs. 
 
Studies have suggested that REs had played an important role in the primate 
evolutionary history [106, 109-111]. Although several groups have focused on 
identifying REs that are uniquely present in the human genome ever since the human 
genome sequence was published in 2002, they were either focusing on either a particular 
RE subfamily/family or a particular out-group family which was limited by the lack of 
resources at the time of their studies [112-115]. This is the first comprehensive study 
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utilizing the human reference genome with a larger number of closely related primate 
out-group genomes.  
The biggest advantage to utilize four out-group genomes is that it ensures maximum 
accuracy. As variations accumulate during the long primate evolutionary history, the out-
group genomes can be quite diverged compared with the human genome for certain 
regions in the genomes. This would affect the quality of the results if only one out-group 
genome is used. For example, although there is no known mechanism to specifically 
remove a RE element, the whole region could be deleted in the out-group genome.  If a 
locus is completely deleted in an out-group genome, it will generate false-positive of a 
HS-RE based on that genome. However, the chances for all four out-group genomes to 
share a deletion at the same locus are very small. As an example for this, a RE element is 
present in both Orangutan genome and Rhesus monkey genome but is absent in the 
Chimpanzee genome (Figure 13). This is truly a shared insertion and the absence in the 
chimpanzee genome could have been caused by either a deletion in the chimpanzee 
genome or an error during sequencing/annotation of the chimpanzee assembly. Even 
though the chimpanzee genome is the least diverged when compared with the human 
genome among all the out-group genomes, the use of other out-group genomes helps to 
eliminate this and other types of false positives. 
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 Figure 13. A screenshot of a shared RE elements in UCSC genome browser 
The black box which is labeled as SINE indicates an Alu insertion. Brown boxes indicate the orthologous 
sequence is present in the out-group genome while open line suggests that it is missing. 
 
9.1.2. Combination of BLAT and liftOver based methods 
 
The reason for using BLAT based method and liftOver based method is that they 
both have limitations. The main principle of the BLAT based method is to examine the 
human specific status of a RE by searching for similar sequences of the REs junction 
areas. However, as previously discussed, mutations can easily occur during the long 
primate evolutionary history. So if the junction area is too diverged, BLAT won’t be able 
to report it as a positive hit, this will result in false-positive HS-REs. One the other end, a 
sequence can be due to the presence of a tandem duplication of the whole insertion region 
or an RE inserted into same type of REs. 
The liftOver based method relies on the previous generated chain file. Unlike the 
BLAT based method, which utilize short local sequences, the chain files are generated by 
constructing alignments between two genomes where the examined region are much 
longer. However, it has its own drawback. As the liftOver is based on a non-overlap 
chain, each group of positions could have only one hit on the out-group genome. If 
tandem duplications of the region containing REs happen after the human-primate 
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divergence, liftOver would treat the duplicated REs as HS-RE while they are true 
negatives. Whereas the BLAT based method can find a good hit of the original RE since 
it’s based on sequence similarity. Also, there are mistakes in the liftOver chain file as 
well. For example, for entry 00644388, the liftOver based method returns a “-/+/+” 
pattern indicating it is a Type I HS-RE. However, the BLAT based method suggests that 
it is truly a shared RE (“-/-/+”). Manual review has confirmed the BLAT based result. 
The liftOver based method has lifted the 5’ flanking of the RE insertion onto a gap region 
on the chimpanzee genome.   
The combination of BLAT and liftOver based results have provided a more accurate 
list of HS-REs. Among all the classes, Class I and Class III have the highest confidence 
level since they are supported by both BLAT and liftOver based methods. Class I cases 
can be a valuable resource for studying mechanism of retrotransposition since they 
provide detailed information of the pre-integration site that are useful for identifying 
TSDs, while there is no accurate pre-integration site information for most of the Class III 
entries. 
 
9.1.3. The value of using RIPs as training and testing dataset 
 
The biggest challenge in the method development of this study is how to determine 
the optimal criteria for identifying HS-REs. Instead of arbitrarily assigning each criterion, 
a training dataset containing known RIPs are used to generate a simulation in the human 
genome.  
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As previously discussed, the RIPs in the human genome represent RE insertions that 
are polymorphic within humans as a result of RE insertions that have occurred after the 
separation of humans and chimpanzees, thus they should be human specific. This unique 
characteristic of RIPs has provided an ideal training dataset for identifying HS-REs. 
Therefore, we choose to use a set of parameters for the BLAT based and liftOver based 
methods that provide a sensitivity of at least 95% in detecting RIPs as HS-REs. The 
specific criteria are as previously discussed in section 7.2.4 and 8.2. 
To assess the quality final HS-RE list, a validation dataset is also used. As described 
in section 7.3, a total of 779 novel RIPs, not included in dbRIP, are used to examine the 
sensitivity of our analysis method, and the test indicated a sensitivity of 96.1%, 
suggesting that our HS-RE list should have covered the most of such REs in the human 
genome.  Unfortunately, unless we experimentally validate these HS-REs by confirming 
their absence in the orthologous regions in the other primate genomes, we will not be able 
to assess the false positive rate of our data. With experimental validation, it would be 
very difficult if possible to confirm Type II HS-REs due to the absence of the flanking 
genome regions in the other genomes. However, with the further improvement of 
reference genome sequences for all involved species, we can expect that some of the false 
positives may be identified and eliminated. 
 
 
 
 
9.2. HS-RE activity level 
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 Recent studies have suggested that the majority of known polymorphic Alu 
insertions belong to the close related Y subfamilies [116-118]: among the 2569 Alu RIPs 
in dbRIP, 2491 of which are members from AluY subfamily [100]. The Ya5 and Yb8 are 
the major subfamilies among the Y family, containing 809 and 918 entries in dbRIP, 
respectively [100]. Data suggested that L1HS is the major subfamily of known 
polymorphic L1 insertion: 446 entries among 598 total L1 RIPs in dbRIP [100]. SVA_E 
SVA_D and SVA_F made up the majority of known polymorphic SVA insertions. 
HERV-K is the only subfamily, which is known to have current activity in the human 
genome [107].  
In these studies, researchers have mainly used RIPs as a tool to evaluate the activity 
level of certain subfamilies during human evolution [90]. The human and chimpanzee 
divergence happened ~6 My ago and modern humans and Neanderthals likely diverged in 
Africa ∼300,000–700,000 yr ago[119]. This suggests that during evolutionary history, 
there would be a proportion of REs in the human genome, which is unique to human. 
Although RIPs would be human specific, they represent only a small portion of all HS-
REs, and it would be insufficient for illustrating the retrotransposition activity level of a 
certain subfamily during human evolutionary history. Since our method imposes no bias 
to identify a specific subfamily, our results provide the first large and unbiased data set 
suitable for assessment of RE insertion activities after the human and chimpanzee 
divergence.   
While our data confirms the previous observation that Ya5 and Yb8 are very active 
Alu subfamilies within the human lineage, it also suggests that other Alu subfamilies such 
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as Yb9, Yd8, Yg6, Yk12, Ya8, Yf4, Yc5 and Yh9 also have very high retrotransposition 
activity. The AluY is the most successful Alu family within the human genome. As 
confirmed by our result, L1HS is the most successful L1 subfamily.  Moreover, our data 
suggests that L1PA2 and HAL1-2a_MD are very also active in the human lineage. Based 
on our result, it could be estimated that the current RIPs from the L1PA2 subfamily are 
only a proportion of what is in the human genome: among the 1135 L1HS reported as 
human specific by our result, 448 of which are reported RIPs; while for L1PA2, there are 
only 24 reported RIPs up to date despite the fact it has more human specific entries (1977 
HS-L1PA2 compared to 4699 all L1PA2). Similar conclusions could be made for the 
SVA subfamily: despite their high retrotransposition activity level suggested by our 
results (1526 HS-SVA in total), there are only 77 reported RIP cases to date. Being the 
youngest RE family, which originated ~25My ago [27], SVA is the most active family in 
the human genome, and therefore we could expect to identify more RIPs from this 
subfamily. Our result confirms that HERVK subfamily is the most active LTR subfamily 
in the human lineage. However, the fact that HERVK has a ~3% HS-ratio may suggest 
that the current 9 entries in dbRIP represent only a proportion of the HERVK insertion 
polymorphism in the human genome. Also, the ERV1 family is showing appreciable 
retrotransposition activity: with 344 HS-ERV1 comparing to 218 HS-HERVK. We can 
thus expect to find more ERV1 RIPs in the human genome.  
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9.3. The bias of HS-REs for chromosome Y  
 
As shown in section 8.7.3, the HS-RE density, as well as the HS-RE and gene 
density ratio on chromosome Y is significantly higher than all other chromosomes. Also, 
as previously discussed in section 8.7.5, the HS-LTR on chromosome Y has contributed 
to over 60% of its total size contribution. Therefore, it is clear that HS-REs are most 
successful on chromosome Y. Three of the four RE families examined (Alu, L1 and LTR) 
have their HS-REs showing strong relative bias towards chromosome Y. 
As previously discussed (section 8.7.3), we suspected such strong bias towards 
chromosome Y could have contributed by the poor quality of out-group chromosome Y. 
However, our results suggested that the gap regions on the chimpanzee chromosome Y 
didn’t cause any false positives. The absence of other out-group chromosome Y sequence 
data could also contribute to false positive Type II HS-REs. There could be some REs 
that are shared by humans and other primates but not chimpanzee. However, 
chimpanzees are the closet related primate to humans. In theory, other primates should be 
less related to human and therefore contain less shared REs with humans on their 
chromosome Y. Based on these, we would consider that there is a chromosome Y bias in 
HS-REs. However future studies are needed to further validate such bias with the 
availability of chromosome Y sequence data from other primates.  
Several groups have focused on examining the distribution pattern of REs between 
the sex chromosomes and autosomes. Based on their findings, the young members in the 
Alu family (mainly AluYs) have two times higher density on chromosome Y than on 
autosomes [120]. Recent studies suggest that the young L1 subfamily (primate-specific 
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L1Ps) have a significantly higher density on the sex chromosomes when compared to 
autosomes [121, 122]. These finding are supported by our results that HS-Alu and HS-L1, 
which are mainly young members in the family, are significantly biased to chromosome 
Y: the HS-Alu density on chromosome Y is almost six times higher than the density of 
autosomes; the HS-L1has an eight times higher density on chromosome Y. In addition, 
our results showed for the first time that human specific LTRs are also significantly 
biased to chromosome Y, with a ~45 times higher density on chromosome Y than 
autosomes. How did this bias happen during evolutionary history? There are no currently 
known mechanisms contribute to this chromosome Y bias. However, several hypotheses 
have been proposed.  
According to the male germline hypothesis, the densities of REs on each 
chromosome types should positively correlate with the amount of time spent in the male 
germline.  Assuming cell division is mutagenic and the number of germ cell divisions is 
larger in males than in females (as is likely in most mammals), male is expected to be 
main source of mutations. The autosomes have a ½ chance carried by the male while 
chromosome Y is always carried by the male. Chromosome X, however, has a 1/3 chance 
carried by the male. In theory, as per generation, the maximum mutation frequency 
between autosomes and sex chromosomes would be Y:A:X = 6:3:2[123]. This hypothesis 
is supported by the observed Y>A>X density of young Alus[120].  
Another hypothesis is that the RE density on chromosome Y is facilitated by the low 
recombination-driven deletion in chromosome Y. As chromosome Y does not recombine 
with chromosome X outside of the pseudo-autosomal regions, it would have higher RE 
density than the autosomes. However, this hypothesis is not supported by our results that 
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the HS-RE density and shared RE density are higher on the pseudo-autosomal regions 
than the male specific regions on chromosome Y (Data not shown).  
Natural selection might also be contributing to the chromosome Y bias: chromosome 
Y has a lower frequency of DNA recombination due to lack of homologous regions 
[122]. DNA recombination-mediated deletion can serve as a mechanism for removing RE 
insertions in a way biased for those with negative functional impact via selection.  
Because chromosome Y has much fewer genes than any other chromosomes, it is facing a 
lower level of selection pressure and lower rate of insertion removal.  
However, none of these mentioned hypotheses could explain why this bias is 
observed for HS-RE but not for shared REs, nor can one explain why HS-SVA is not 
showing such chromosome Y bias. Although genetic decay may be the principal dynamic 
in the evolution of chromosome Y, recent studies suggested that remodeling and 
regeneration have dominated chimpanzee and human male specific chromosome Y 
evolution during the past 6 million years[124]. This could potentially explain the success 
of HS-REs on chromosome Y.  
Assuming this bias is valid, how would it affect chromosome Y?  Recently, there 
has been a heated debate among the science community about whether chromosome Y is 
disappearing or not [125]. Our result could serve as evidence that “chromosome Y has 
not disappeared yet” [125] and HS-REs may have contributed to the observed fast 
evolving pattern on chromosome Y after the human and chimpanzee divergence [124]. 
However, the potential functional impact about the preferential insertion of HS-RE on 
chromosome Y is still unknown.  
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 10.  Summary and future perspectives 
 
Transposable elements play important roles in genome evolution and function in 
most higher organisms, including humans. Although several groups have looked into the 
genetic diversity contributed by retrotransposons between human and other primates, they 
have focused on either a specific family of retrotransposons or a specific primate, leaving 
the total number of human specific transposable elements largely undetermined. In this 
study, we took advantage of the availability of the human genome sequences and a few 
non-human primate genome sequences to study the impact of retrotransposons on the 
human genome from several aspects.  
By computationally comparing the human genome to 4 primate genomes, we 
identified a total of 18,860 HS-REs, among which are 11,664 Alus, 4,887 L1s, 1,526 
SVAs and 783 LTRs (222 full length entries), representing the largest and most 
comprehensive list of HS-REs generated to date. Together, these HS-REs contributed a 
total of 14.2Mb sequence increase from the inserted REs and Target Site Duplications 
(TSDs), 71.6Kb increase from transductions, and 268.2 Kb sequence deletion of from 
insertion-mediated deletion, leading to a net increase of ~14 Mb sequences to the human 
genome. Furthermore, we observed for the first time that Y chromosome might be a hot 
target for new retrotransposon insertions in general and particularly for LTRs. Many of 
these HS-REs insert into gene regions, including exon, promoter, and intron regions, with 
high potential for direct impact on gene regulation, splicing and protein coding.  All these 
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data suggest that retrotransposon elements have played a significant role in the evolution 
of Homo sapiens. 
Many directions of future study may be explored to further characterize the specific 
impact of transposable elements on human genome evolution and function. First, with the 
availability of personal genome data from the 1000 genome project and many large 
personal genome projects alike, it is possible to focus on identifying population specific 
REs and their contribution to the phenotypic differences observable among different 
population. Second, the functional impact of all human specific transposable elements on 
the associated genes can be examined experimentally, perhaps by using a combination of 
animal model, in vitro study, and disease association study, and by giving those in 
located in the genic region higher priority.   Last, but not least, similar study can be 
applied to each of the other primate species to provide an assessment of transposable 
elements’ functional impact on evolution of the species and and the unique biology.  
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